Kari Nadeau CV

CURRICULUM VITAE FOR KARI C.
NADEAU, MD, PHD
I. Information
Stanford Hospital Address:
300 Pasteur Drive
Stanford, CA 94305
Office Address:
Biomedical Innovations Building (BMI)
240 Pasteur Drive, Room#1755
Palo Alto, CA 94304
Laboratory Address:
Sean N. Parker Center for Allergy & Asthma Research at Stanford University,
Nadeau Laboratory at Biomedical Innovations Building (BMI)
240 Pasteur Drive, #1700
Palo Alto, CA 94304
Clinical and Translational Research Unit (CTRU) Address:
Sean N. Parker Center for Allergy and Asthma Research at Stanford University,
Lucile Packard Children’s Hospital at El Camino Hospital
2500 Grant Road, 4th floor, Tower C, Room 4C347
Mountain View, CA 94040
Sean N. Parker Center Clinic Address:
Sean N. Parker Center for Allergy and Asthma Research at Stanford University,
Lucile Packard Children’s Hospital
725 Welch Road, Suite 183,
Stanford, CA 94304
Email: knadeau@stanford.edu
Web: https://med.stanford.edu/profiles/kari-nadeau
http://med.stanford.edu/allergyandasthma.html
http://med.stanford.edu/pulmonary.html
http://med.stanford.edu/pedair.html
II. Licensures
 DEA: BN7628742
 P
1
CURRICULUM VITAE FOR KARI C. NADEAU, MD, PHD
 California Medical License: G85871
III. Google Scholar Indices

 Citations: 19,039, H index: 68, i10 index: 193
IV. Certifications
 2008: Elected Fellow of the American Academy of Allergy, Asthma, and Immunology
 2007: Board Certification in Allergy and Immunology
 2006: Board Certification in Pediatrics
V. Educational Background
 2003-2006: Fellow, Stanford-UCSF Allergy, Asthma and Immunology Program
 1995-1997: Pediatric Internship and Residency, Pediatrics, Children's Hospital of Boston
Special Alternative Pathway
 1988-1995: MD and PhD at Harvard Medical School, Medical Scientist Training Program
Doctoral work completed in Biochemistry and Immunology, Boston, MA
 1984-1988: BS in Biology, Haverford College, Summa cum Laude, Haverford, PA
VI. Professional Appointments (Stanford University School of Medicine)

 Jul. 2020 -present: Professor of Epidemiology, Department of Epidemiology and Population
Health (courtesy appointment)
 Jun. 2015-present: Professor of Otolaryngology, Department of Otolaryngology (courtesy
appointment)
 Jun. 2015-present: Professor of Pediatrics, Division of Allergy, Immunology, and
Rheumatology (joint appointment)
 Jun. 2015-present: Professor of Medicine. Division of Pulmonary and Critical Care Medicine
 Jan. 2015-present Director, Sean N. Parker Center for Allergy and Asthma
Research at Stanford University
 2010-present: Member, Children’s Health Research Institute, Stanford
 2007-present: Faculty Member, Multidisciplinary Program in Immunology (MPI),
Stanford University School of Medicine, Stanford, CA
 2007-present: Faculty Member, Stanford Institute of Immunity, Transplantation, and
Infectious Disease
 June 2015-Sept. 2015: Associate Professor of Pediatrics (MCL), Division of Allergy,
Immunology, and Rheumatology (joint appointment)
 June 2015-Sept. 2015: Associate Professor of Medicine (MCL), Division of Pulmonary and
Critical Care Medicine
 Aug. 2011-Sept. 2015: Associate Professor of Otolaryngology (MCL), Courtesy Appointment
2
 Aug. 2011-May 2015: Associate Professor of Pediatrics (MCL), Division of Allergy,

Immunology, and Rheumatology
 June 2008-July 2011: Assistant Professor of Otolaryngology (MCL), Courtesy Appointment
 June 2008-July 2011: Assistant Professor of Pediatrics (MCL), Division of Immunology and
Allergy
 July 2006-May 2008: Instructor, Department of Pediatrics
 Nov. 2005-June 2006: Post-doctoral fellow, Laboratory of Dr. Alan Krensky, Clinical Fellow,
Allergy and Immunology
 Nov. 2002-Oct. 2005: Clinical Instructor, General Pediatrics
VII. Other Employment History

 2002-2003: Vice President of Medical Development and Chief Scientific Officer,
Clearview Projects. S. San Francisco, CA. and Princeton, NJ. Oversaw and
led scientific review of new diagnostic or therapeutic products and devices of
clients (biotechnology companies in U.S., Europe, Japan, and Australia) and
wrote development plans and research protocols in allergy, cancer, and
autoimmune diseases.
 2000-2001: Medical Director, Coulter Pharmaceuticals. S. San Francisco, CA.
Directed clinical studies in lymphoma and leukemia with an anti- CD20
antibody (Bexxar®), and worked on approval of Bexxar® by the FDA.
 1998-2000: Associate Medical Director, Biogen. Cambridge, Mass. Directed the anti-
CD40L antibody program by writing and leading the clinical research
studies for children and adults with allergy, autoimmune diseases, and
organ transplantation.
VIII. Honors and Awards

 Distinguished Member. World Society for Virology (2021-present)
 Member, EU Academy of Sciences (EUAS) (2021-present)
 Advisory Board for the EAACI Research and Outreach Committee (2020 – present)
 Member, Association of American Physicians (2020)
 American Academy of Allergy, Asthma and Immunology (AAAAI) National Distinguished
Scientist Award (2020)
 Nominee from Stanford Medical School for Warren Alpert Award (2020)
 Stanford Cardiovascular Institute Seed Grant Award, “Single-cell Sequencing to Identify Air
Pollution-Induced Cardiac Risks.” (2019)
 Senior Fellow, Stanford Woods Institute for the Environment (2019-current)
3
 Chief Innovation Officer, Food Allergy Research & Education (FARE) (2018-present)
 Food Allergy Research & Education (FARE), Distinguished Research Award (2018)
 Chair, Board of Scientific Counselors of NIH Clinical Centers (CCBSC) (2018-current)
 White House Medical Unit Consultant (2015- 2016)
 National Scientific Advisory Board Environmental Protection Agency (2015-2016)
 Member, National Scientific Committee, Immune Tolerance Network, NIAID (2015-
present)
 Institute of Medicine, National Academy of Sciences (U.S.), Consultant and Panel
Participant (2014)
 Faculty Fellow, Stanford Center for Innovation in Global Health (2015-Present)
 United Nations Annual Innovations Lecture “An Allergy Free World For Every Child”
(2015)
 University of Washington Grand Rounds and Pierson Lectureship (2015)
 Texas Children’s Hospital Visiting Professorship Lecture (2015)
 Distinguished Lecture Award, NIEHS Annual Distinguished Lecture (2014)
 Member, The American Society of Clinical Investigation (2014)
 American Academy of Asthma, Allergy, and Immunology Research Award (2014)
 Helen F. Cserr Memorial Lecture Award (2014)
 Canadian Allergy and Clinical Immunology Society Plenary Speaker Award (2013)
 Member and Alain L. de Weck Travel Grant Awardee, Collegium Internationale
Allergologicum (2012)
 Faculty Fellows Program Award, Stanford University School of Medicine (2012-2013)
 EPA Star Grant Award (2011-2013)
 Clinical Immunological Society (CIS) Junior Faculty Award (2010)
 Council for Collegium Internationale Allergologicum (2010-present)
 American Lung Association National Junior Faculty Award (2009)
 Fellow of the American Academy of Asthma, Allergy and Immunology (2008-present)
 ART trust American Academy of Allergy, Asthma and Immunology Award (2008)
 International CIS Immunodeficiency School for Fellows (faculty member) (2008- 2011)
 Speaker Award, La Entrada Inspirational Speaker Series (2007)
 Teaching Award, Stanford Cardinal Free Clinic (2007)
 Speaker Awardee, American Society of Transplantation (5/97, 5/98, 5/99)
 Von Mayer Scholarship Awardee, Children’s Hospital (1995-1998)
4
 Soma Weiss Speaker for Harvard Medical School (1993)

 Medical Student Teaching Award, Harvard Medical School (6/91, 6/92, 6/93)
IX. Policy and Community Service/Outreach

 Member, Center for Planetary Health at Stanford (2020-current)
 Lancet Countdown on Health and Climate Change (2020).
 Leader of Pediatric Forum at the CA Governor’s Conference on Climate Change (2018)
 Co-led and organized (with Lane Center for the West and the Woods Institute,
Stanford) symposium of rural health and effects of the global climate change and extreme
weather conditions at Stanford University. (January 2018)
 Co-sponsored and participant in Global Health Women’s Conference at Stanford
University (October 2017, Stanford)
 Expert consultant, California State Legislature on Climate Change, Wildfires, and Health
(2015-present)
 Expert consultant, Food Allergy and Anaphylaxis guidelines for children, Office of Nancy
Pelosi, Speaker of the House (2014-2016)
 Led multiple NIH-sponsored workshops and groups for immunology, allergy, and/or asthma
(2013-present)
 Education and Outreach on Allergies and Asthma to the Underserved (2013- present).
 Lectures to hospital emergency rooms on allergy/extreme weather conditions emergencies
throughout the U.S. (2011-present).
 Lectures to public health departments on effect of allergy, environmental exposures and
allergy and asthma (2007-present).
 Expert consultant in air pollution effects on health, U.S. Congress for Senator Whitehouse
(July 2017)
 Host, American Lung Association Asthma Educator Conference 2017. Stanford, CA.
 Lecturer, American Lung Association Asthma Educator Conference 2013, Berkeley, CA.
 Webinar Lectures, Environmental Protection Agency and NIH NIEHS “Ambient Air Pollution
and Immune Changes in Children” (2013, 2017) and “Epigenetic Changes after Ambient Air
Pollution” (2014, 2016)
 Webinar Lecture, American Lung Association “Risk of Air Pollution in Children” (2014)
 Civil Service: Expert for Hearings in CA. State Legislature on Air Pollution Bill (2013) and,
separately, on Injectable Epinephrine Bill (2014, 2016).
 Volunteer at Free Clinic, Stanford University Medical School, 2002-2012.
 Guest speaker on Biological Therapies at Massachusetts State Legislature (2000)
5
 Member, Board of Directors, Lupus Foundation of Massachusetts (1998-2000)

 Lectures to local schools on allergies, 1:1 education of teachers/nurses in local schools on
food allergies.
X. Scholarly Publications
A. Peer-reviewed Journal Articles
1. Krempski JW, Warren C, Han X, Zhang W, He Z, Lejeune S, Nadeau K. Food Allergies: An

Example of Translational Research. Immunol Allergy Clin North Am. 2021 May;41(2):143-
163.
2. Nygaard UC, Xiao L, Nadeau KC, Hew KM, Lv N, Camargo CA, Strub P, Ma J. Improved
diet quality is associated with decreased concentrations of inflammatory markers in adults
with uncontrolled asthma. Am J Clin Nutr. 2021 Apr 19 [Epub ahead of print].
3. Nadeau KC. Allergen Specific IgG Antibodies for Cat Allergy? Am J Respir Crit Care Med.
2021 Apr 15. [Epub ahead of print].
4. Camiolo MJ, Zhou X, Oriss TB, Yan Q, Gorry M, Horne W, Trudeau JB, Scholl K, Chen W,
Kolls JK, Ray P, Weisel FJ, Weisel NM, Aghaeepour N, Nadeau K, Wenzel SE, Ray A.
High-dimensional profiling clusters asthma severity by lymphoid and non-lymphoid status.
Cell Rep. 2021 Apr 13;35(2):108974.
5. Yang F, Nielsen SCA, Hoh RA, Röltgen K, Wirz OF, Haraguchi E, Jean GH, Lee JY, Pham
TD, Jackson KJL, Roskin KM, Liu Y, Nguyen K, Ohgami RS, Osborne EM, Nadeau KC,
Niemann CU, Parsonnet J, Boyd SD. Shared B cell memory to coronaviruses and other
pathogens varies in human age groups and tissues. Science. 2021 Apr 12 [Epub ahead of
print].
6. Jeong DE, McCoy M, Artiles K, Ilbay O, Fire A, Nadeau K, Park H, Betts B, Boyd S, Hoh
R, Shoura M. Assemblies of putative SARS-CoV2-spike-encoding mRNA sequences for
vaccines BNT-162b2 and mRNA-1273. Github. In review.
7. Sampath V, Rabinowitz G, Shah M, Jain S, Diamant Z, Jesenak M, Rabin R, Vieths S,
Agache I, Akdis M, Barber D, Breiteneder H, Chinthrajah S, Chivato T, Collins W,
Eiwegger T, Fast K, Fokkens W, O'Hehir RE, Ollert M, O'Mahony L, Palomares O, Pfaar O,
Riggioni C, Shamji MH, Sokolowska M, Torres MJ, Traidl-Hoffmann C, van Zelm M,
Wang Y, Zhang L, Akdis C, Nadeau KC. Vaccines and Allergic reactions: the past, the
current COVID-19 pandemic, and future perspectives. Allergy. 2021 Apr 2.
8. Skevaki C, Karsonova A, Karaulov A, Fomina D, Xie M, Chinthrajah S, Nadeau KC, Renz
H. SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship. Nat Rev
Immunol. 2021 Apr;21(4):202-203.
9. Mann JK, Lutzker L, Holm SM, Margolis HG, Neophytou AM, Eisen EA, Costello S, Tyner
T, Holland N, Tindula G, Prunicki M, Nadeau K, Noth EM, Lurmann F, Hammond SK,
Balmes JR. Traffic-related air pollution is associated with glucose dysregulation, blood
pressure, and oxidative stress in children. Environ Res. 2021 Apr;195:110870.
6
10. Dreskin SC, Koppelman SJ, Andorf S, Nadeau KC, Kalra A, Braun W, Negi SS, Chen X,
Schein CH. The importance of the 2S albumins for allergenicity and cross-reactivity of
peanuts, tree nuts, and sesame seeds. J Allergy Clin Immunol. 2021 Apr;147(4):1154-1163.
11. Manohar M, Dunham D, Gupta S, Yan Z, Zhang W, Minnicozzi S, Kirkey M, Bunning B,
Chowdhury RR, Galli SJ, Boyd SD, Kost LE, Chinthrajah RS, Desai M, Oettgen HC,
Maecker HT, Yu W, DeKruyff RH, Andorf S, Nadeau KC. Immune Changes Beyond Th2
Pathways During Rapid Multifood Immunotherapy enabled with Omalizumab. Allergy. 2021
Mar 30. [Epub ahead or print].
12. Huang Y, Radenkovic D, Perez K, Nadeau K, Verdin E, Furman D. Modeling Predictive
Age-Dependent and Age-Independent Symptoms and Comorbidities of Patients Seeking
Treatment for COVID-19: Model Development and Validation Study. J Med Internet Res.
2021 Mar 25;23(3):e25696.
13. Zhou X, Han X, Lyu SC, Bunning B, Kost L, Chang I, Cao S, Sampath V, Nadeau KC.
Targeted DNA methylation profiling reveals epigenetic signatures in peanut allergy. JCI
Insight. 2021 Mar 22;6(6):143058.
14. Sweeney A, Sampath V, Nadeau KC. Early intervention of atopic dermatitis as a preventive
strategy for progression of food allergy. Allergy Asthma Clin Immunol. 2021 Mar
16;17(1):30.
15. Halken S, Muraro A, de Silva D, Khaleva E, Angier E, Arasi S, Arshad H, Bahnson HT,
Beyer K, Boyle R, du Toit G, Ebisawa M, Eigenmann P, Grimshaw K, Hoest A, Jones C,
Lack G, Nadeau K, O'Mahony L, Szajewska H, Venter C, Verhasselt V, Wong GW, Roberts
G; European Academy of Allergy and Clinical Immunology Food Allergy and Anaphylaxis
Guidelines Group. EAACI guideline: preventing the development of food allergy in infants
and young children (2020 update). Pediatr Allergy Immunol. 2021 Mar 12. [Epub ahead of
print].
16. Haber LT, Reichard JF, Henning AK, Dawson P, Chinthrajah RS, Sindher SB, Long A,
Vincent MJ, Nadeau KC, Allen BC. Bayesian Hierarchical Evaluation of Dose-Response
for Peanut Allergy in Clinical Trial Screening. Food and Chemical Toxicology. March 12,
2021.
17. Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, Marconi VC,
Ruiz-Palacios GM, Hsieh L, Kline S, Tapson V, Iovine NM, Jain MK, Sweeney DA, El
Sahly HM, Branche AR, Regalado Pineda J, Lye DC, Sandkovsky U, Luetkemeyer AF,
Cohen SH, Finberg RW, Jackson PEH, Taiwo B, Paules CI, Arguinchona H, Erdmann N,
Ahuja N, Frank M, Oh MD, Kim ES, Tan SY, Mularski RA, Nielsen H, Ponce PO, Taylor
BS, Larson L, Rouphael NG, Saklawi Y, Cantos VD, Ko ER, Engemann JJ, Amin AN,
Watanabe M, Billings J, Elie MC, Davey RT, Burgess TH, Ferreira J, Green M, Makowski
M, Cardoso A, de Bono S, Bonnett T, Proschan M, Deye GA, Dempsey W, Nayak SU, Dodd
LE, Beigel JH; ACTT-2 Study Group Members. Baricitinib plus Remdesivir for
Hospitalized Adults with Covid-19. N Engl J Med. 2021 Mar 4;384(9):795-807. (listed under
study team members)
7
18. Zhou X, Yu W, Lyu SC, Macaubas C, Bunning B, Mellins ED, Nadeau KC. A positive
feedback loop reinforces the allergic immune response in human peanut allergy. J Exp Med.
Accepted March 4, 2021. In Press.
19. Nadeau K. Serving up hope. New Scientist. 2021 March; 249 (3325):23.
20. Pfaar O, Klimek L, Jutel M, …, Nadeau KC, …, Agache I. COVID-19 pandemic: Practical
considerations on the organization of an allergy clinic-An EAACI/ARIA Position
Paper. Allergy. 2021 Mar;76(3):648-676.
21. He Z, Vadali VG, Szabady RL, Zhang W, Norman JM, Roberts B, Tibshirani R, Desai M,
Chinthrajah RS, Galli SJ, Andorf S, Nadeau KC. Increased diversity of gut microbiota
during active oral immunotherapy in peanut-allergic adults. Allergy.2021 Mar;76(3):927-
930.
22. Bousquet J, Jutel M, Akdis CA, …, Nadeau KC, …, Agache I. ARIA-EAACI statement on
asthma and COVID-19 (June 2, 2020). Allergy. 2021 Mar;76(3):689-697.
23. Goshua A, Gomez J, Erny B, Burke M, Luby S, Sokolow S, LaBeaud AD, Auerbach P,
Gisondi MA, Nadeau K. Addressing Climate Change and Its Effects on Human Health: A
Call to Action for Medical Schools. Acad Med. 2021 Mar 1;96(3):324-328.
24. Rosas IO, Bräu N, Waters M, Go RC, Hunter BD, Bhagani S, Skiest D, Aziz MS, Cooper N,
Douglas IS, Savic S, Youngstein T, Del Sorbo L, Cubillo Gracian A, De La Zerda DJ,
Ustianowski A, Bao M, Dimonaco S, Graham E, Matharu B, Spotswood H, Tsai L, Malhotra
A. Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia. N Engl J Med.
2021 Feb 25. [Epub ahead of print]. (listed under Study team members)
25. Balz K, Kaushik A, Chen M, Cemic F, Heger V, Renz H, Nadeau K, Skevaki C. Homologies
between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous
immune responses. Sci Rep. 2021 Feb 26;11(1):4792.
26. Prunicki M, Cauwenberghs N, Lee J, Zhou X, Movassagh H, Noth E, Lurmann F, Hammond
SK, Balmes JR, Desai M, Wu JC, Nadeau KC. Air pollution exposure is linked with
methylation of immunoregulatory genes, altered immune cell profiles, and increased blood
pressure in children. Sci Rep. 2021 Feb 18;11(1):4067.
27. Sahiner UM, Layhadi JA, Golebski K, István Komlósi Z, Peng Y, Sekerel B, Durham SR,
Brough H, Morita H, Akdis M, Turner P, Nadeau K, Spits H, Akdis C, Shamji MH. Innate
Lymphoid Cells: The Missing Part Of A Puzzle In Food Allergy. Allergy. 2021 Feb 14 [Epub
ahead of print].
28. Muehe A, Nejadnik H, Muehe H, Rosenberg J, Gharibi H, Saei AA, et al. Can the
biomolecular corona induce an allergic reaction?—A proof-of-concept study. Biointerphases
2021;16:011008.
29. Sharif H, Acharya S, Dhondalay GKR, Varricchi G, Krasner-Macleod S, Laisuan W, Switzer
A, Lenormand M, Kashe E, Parkin RV, Yi Y, Koc M, Fedina O, Vilà-Nadal G, Marone G,
Eifan A, Scadding GW, Fear DJ, Nadeau KC, Durham SR, Shamji MH. Altered chromatin
landscape in circulating T follicular helper and regulatory cells following grass pollen
8
subcutaneous and sublingual immunotherapy. J Allergy Clin Immunol. 2021

Feb;147(2):663-676
30. Bao R, Hesser LA, He Z, Zhou X, Nadeau KC*, Nagler CR*. Fecal microbiome and
metabolome differ in healthy and food-allergic twins. J Clin Invest. 2021 Jan
19;131(2):141935. (*Co-senior authors).
31. Yan Z, Maecker HT, Brodin P, Nygaard UC, Lyu SC, Davis MM, Nadeau KC, Andorf S.
Aging and CMV discordance are associated with increased immune diversity between
monozygotic twins. Immun Ageing. 2021 Jan 18;18(1):5.
32. Sokolowska M, Eiwegger T, Ollert M, Torres MJ, Barber D, Del Giacco S, Jutel M, Nadeau
KC, Palomares O, Rabin RL, Riggioni C, Vieths S, Agache I, Shamji MH. EAACI statement
on the diagnosis, management and prevention of severe allergic reactions to COVID-19
vaccines. Allergy. 2021 Jan 16. [ Epub ahead of print].
33. Turner-Bowker DM, Jalbert JJ, Krohe M, Yaworsky A, Kelly MT, Padilla B, Chaston E,
Radin A, Mastey V, Nadeau KC. A novel patient-reported outcomes instrument assessing
the side effects of peanut oral immunotherapy. Ann Allergy Asthma Immunol. 2021
Jan;126(1):61-68.
34. Yu W, Zhou X, Lyu SC, Davis MM, Nadeau KC. Regulation of peanut-specific CD8+ T
cells from nonallergic individuals. J Allergy Clin Immunol. 2021 Jan;147(1):385-387.e1.
35. Chakraborty S, Gonzalez J, Edwards K, Mallajosyula V, Buzzanco AS, Sherwood R,
Buffone C, Kathale N, Providenza S, Xie MM, Andrews JR, Blish CA, Singh U, Dugan H,
Wilson PC, Pham TD, Boyd SD, Nadeau KC, Pinsky BA, Zhang S, Memoli MJ,
Taubenberger JK, Morales T, Schapiro JM, Tan GS, Jagannathan P, Wang TT.
Proinflammatory IgG Fc structures in patients with severe COVID-19. Nat Immunol. 2021
Jan;22(1):67-73.
36. Neeland MR, Tursi AR, Perrett KP, Saffery R, Koplin JJ, Nadeau KC, Andorf S. Vitamin D
insufficiency is associated with reduced regulatory T cell frequency in food-allergic infants.
Pediatr Allergy Immunol. 2020 Dec 22. [Epub ahead of print].
37. Paranjape A, Tsai M, Mukai K, Hoh RA, Joshi SA, Chinthrajah RS, Nadeau KC, Boyd SD,
Galli SJ. Oral immunotherapy and basophil and mast cell reactivity in food allergy. Front.
Immunol. 2020;11:602660.
38. Duan L, Celik A, Hoang JA, Schmidthaler K, So D, Yin X, Ditlof CM, Ponce M, Upton
JEM, Lee JS, Hung L, Breiteneder H, Palladino C, Atkinson AR, Kim VHD, Berenjy A,
Asper M, Hummel D, Wong S, Alexanian-Farr M, Magder A, Chinthrajah SR, Mukai K,
Tsai M, Nadeau K, Galli SJ, Ramani AK, Szepfalusi Z, Eiwegger T. Basophil activation test
shows high accuracy in the diagnosis of peanut and tree nut allergy: The Markers of Nut
Allergy Study. Allergy. 2020 Dec 9. [Epub ahead of print].
39. Roltgen K, Powell AE, Wirz OF, Stevens BA, Hogan CA, Najeeb J, Hunter M, Wang H,
Sahoo MK, Huang C, Yamamoto F, Manohar M, Manalac J, Otrelo-Cardoso AR, Pham TD,
Rustagi A, Rogers AJ, Shah NH, Blish CA, Cochran JR, Jardetzky TS, Zehnder JL, Wang
9
TT, Narasimhan B, Gombar S, Tibshirani R, Nadeau KC, Kim PS, Pinsky BA, Boyd SD.
Defining the features and duration of antibody responses to SARS-CoV-2 infection
associated with disease severity and outcome. Sci Immunol. 2020 Dec 7;5(54): 0240
40. Gonzalez NV, Oliveria JP, Tebaykin D, Ivison GT, Mukai K, Tsai MM, Borges L, Nadeau
KC, Galli SJ, Tsai AG, Bendall SC. Mass cytometry phenotyping of human granulocytes
reveals novel basophil functional heterogeneity. iScience. 2020 Nov 20;23(11):101724.
41. Wawrzyniak P, Krawczyk K, Swati A, Tan G, Wawrzyniak M, Karouzakis E, Dreher A,
Jakiela B, Altunbulakli C, Sanak M, O'Mahony L, Nadeau K, and Akdis C. Inhibition of
CpG methylation improves the barrier integrity of bronchial epithelial cells in asthma.
Allergy. 2020 Nov 19.
42. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu
HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V,
Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari
N, Oh MD, Ruiz-Palacios GM, Benfield T, Fätkenheuer G, Kortepeter MG, Atmar RL,
Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M,
Makowski M, Osinusi A, Nayak S, Lane HC; ACTT-1 Study Group Members. Remdesivir
for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020 Nov 5;383(19):1813-
1826. (listed under Study team members)
43. Radzikowska U, Ding M, Tan G, Zhakparov D, Peng Y, Wawrzyniak P, Wang M, Li S,
Morita H, Altunbulakli C, Reiger M, Neumann AU, Lunjani N, Traidl-Hoffmann C, Nadeau
K, O'Mahony L, Akdis CA, Sokolowska M. Distribution of ACE2, CD147, CD26 and other
SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma,
COPD, obesity, hypertension, and COVID-19 risk factors. Allergy. 2020 Nov;75(11):2829-
2845.
44. Goyard S, Balbino B, Chinthrajah RS, Lyu SC, Janin YL, Bruhns P, Poncet P, Galli SJ,
Nadeau KC, Reber LL, Rose T. A highly sensitive bioluminescent method for measuring
allergen-specific IgE in microliter samples. Allergy. 2020 Nov;75(11):2952-2956.
45. Krempski JW, Dant C, Nadeau KC. The Origins of Allergy from a Systems Approach. Ann
Allergy Asthma Immunol. 2020 Nov;125(5):507-516.
46. Steffes LC, Froistad AA, Andruska A, Boehm M, McGlynn M, Zhang F, Zhang W, Hou D,
Tian X, Miquerol L, Nadeau K, Metzger RJ, Spiekerkoetter E, Kumar ME. A Notch3-
Marked Subpopulation of Vascular Smooth Muscle Cells is the Cell of Origin for Occlusive
Pulmonary Vascular Lesions. Circulation. 2020 Oct 20;142(16):1545-1561.
47. Han X, Krempski JW, Nadeau K. Advances and novel developments in mechanisms of
allergic inflammation. Allergy. 2020 Dec;75(12):3100-3111.
48. Alkotob SS, Cannedy C, Harter K, Movassagh H, Paudel B, Prunicki M, Sampath V,
Schikowski T, Smith E, Zhao Q, Traidl-Hoffmann C, Nadeau KC. Advances and novel
developments in environmental influences on the development of atopic diseases. Allergy.
2020 Dec;75(12):3077-3086.
10
49. Prunicki M, Cauwenberghs N, Ataam JA, Movassagh H, Kim JB, Kuznetsova T, Wu JC,
Maecker H, Haddad F, Nadeau K. Immune biomarkers link air pollution exposure to blood
pressure in adolescents. Environ Health. 2020 Oct 16;19(1):108.
50. Starkl P, Watzenboeck ML, Popov LM, Zahalka S, Hladik A, Lakovits K, Radhouani M,
Haschemi A, Marichal T, Reber LL, Gaudenzio N, Sibilano R, Stulik L, Fontaine F, Mueller
AC, Amieva MR, Galli SJ, Knapp S. IgE Effector Mechanisms, in Concert with Mast Cells,
Contribute to Acquired Host Defense against Staphylococcusaureus. Immunity. 2020 Oct
13;53(4):793-804.e9.
51. Nielsen SCA, Yang F, Jackson KJL, Hoh RA, Röltgen K, Jean GH, Stevens BA, Lee JY,
Rustagi A, Rogers AJ, Powell AE, Hunter M, Najeeb J, Otrelo-Cardoso AR, Yost KE,
Daniel B, Nadeau KC, Chang HY, Satpathy AT, Jardetzky TS, Kim PS, Wang TT, Pinsky
BA, Blish CA, Boyd SD. Human B Cell Clonal Expansion and Convergent Antibody
Responses to SARS-CoV-2. Cell Host Microbe. 2020 Oct 7;28(4):516-525
52. Kabasser S, Hafner C, Chinthrajah S, Sindher SB, Kumar D, Kost LE, Long AJ, Nadeau KC,
Breiteneder H, Bublin M. Identification of Pru du 6 as a potential marker allergen for
almond allergy. Allergy. 2020 Oct 7;28(4):516-525.e5.
53. Sindher S, Alkotob SS, Shojinaga MN, Brough HA, Bahnson T, S C, Lack G, Leung DYM,
Nadeau KC. Pilot study measuring transepidermal water loss (TEWL) in children suggests
trilipid cream is more effective than a paraffin-based emollient. Allergy 2020
Oct;75(10):2662-2664.
54. Riggioni C, Comberiati P, Giovannini M, Agache I, Akdis M, Alves-Correia M, Antó JM,
Arcolaci A, Azkur AK, Azkur D, Beken B, Boccabella C, Bousquet J, Breiteneder H,
Carvalho D, De Las Vecillas L, Diamant Z, Eguiluz-Gracia I, Eiwegger T, Eyerich S,
Fokkens W, Gao YD, Hannachi F, Johnston SL, Jutel M, Karavelia A, Klimek L, Moya B,
Nadeau KC, O'Hehir R, O'Mahony L, Pfaar O, Sanak M, Schwarze J, Sokolowska M, Torres
MJ, van de Veen W, van Zelm MC, Wang Y, Zhang L, Jiménez-Saiz R, Akdis CA. A
compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy. 2020
Oct;75(10):2503-2541.
55. Wang W, Lyu SC, Ji X, Gupta S, Manohar M, Dhondalay GKR, Chinthrajah S, Andorf S,
Boyd SD, Tibshirani R, Galli SJ, Nadeau KC, Maecker HT. Transcriptional changes in
peanut-specific CD4+ T cells over the course of oral immunotherapy. Clin Immunol. 2020
Oct;219:108568.
56. Sokolowska M, Lukasik Z, Agache I, …Nadeau K, …Untersmayr E. Immunology of
COVID-19: mechanisms, clinical outcome, diagnostics and perspectives - a report of the
European Academy of Allergy and Clinical Immunology (EAACI). Allergy. 2020
Oct;75(10):2445-2476.
57. Chinthrajah RS, Cao S, Dunham T, Sampath V, Chandra S, Chen M, Sindher S, Nadeau K.
Oral immunotherapy for peanut allergy: The pro argument. World Allergy Organ J. 2020
Sep 18;13(8):100455.
11
58. Breiteneder H, Peng YQ, Agache I, Diamant Z, Eiwegger T, Fokkens WJ, Traidl-Hoffmann
C, Nadeau K, O'Hehir RE, O'Mahony L, Pfaar O, Torres MJ, Wang DY, Zhang L, Akdis
CA. Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and
asthma. Allergy. 2020 Sep 7;75(12):3039–68.
59. Prunicki MM, Dant CC, Cao S, Maecker H, Haddad F, Kim JB, Snyder M, Wu J, Nadeau K.
Immunologic effects of forest fire exposure show increases in IL-1β and CRP. Allergy. 2020
Sep;75(9):2356-2358.
60. Brough HA, Nadeau KC, Sindher SB, Alkotob SS, Chan S, Bahnson H, Leung DYM, Lack
G. Epicutaneous sensitization in the development of food allergy: what is the evidence and
how can this be prevented? Allergy. 2020 Sep;75(9):2185-2205. (*: joint first authors, **
joint last authors).
61. Bozen A, Zaslavsky JM, Cohn D, Samady W, Lombard L, Nadeau K, Tobin M, Warren CM,
Gupta RS. Barriers to food allergy management among Americans with low income. Ann
Allergy Asthma Immunol. 2020 Sep;125(3):341-343.
62. Asai Y, Martino D, Eiwegger T, Nadeau K, Koppelman GH, Clarke AE, Lee YA, Chan ES,
Simons E, Laprise C, Mazer B, Marenholz I, Royce D, Elliott SJ, Hampson C, Gerdts J,
Eslami A, Soller L, Hui J, Azad M, Sandford A, Daley D. Phenotype consensus is required
to enable large-scale genetic consortium studies of food allergy. Allergy. 2020
Sep;75(9):2383-2387.
63. Diffenbaugh NS, Field CB, Appel EA, Azevedo IL, Baldocchi DD, Burke M , Burney JA ,
Ciais P, Davis SJ, Fiore AM, Fletcher SM, Hertel TW, Horton DE, Hsiang SM , Jackson RB,
Jin X, Levi M, Lobell DB, McKinley GA, Moore FC, Montgomery A, Nadeau KC, Pataki
DE, Randerson JT, Reichstein M, Schnell JL, Seneviratne SI , Singh D, Steiner AL, Wong-
Parodi G. The COVID-19 lockdowns: a window into the Earth System. Nat Rev Earth
Environ. 2020 Sep;1:470–481.
64. Sindher S, Alkotob SS, Shojinaga MN, Hamilton R, Chan S, Cao S, Bahnson HT, Brough
HA, Lack G, Leung DYM, Nadeau KC. Increases in plasma IgG4/IgE with trilipid vs
paraffin/petrolatum-based emollients for dry skin/eczema. Pediatr Allergy Immunol. 2020
Aug;31(6):699-703.
65. He Z, Dongre P, Lyu SC, Manohar M, Chinthrajah RS, Galli SJ, DeKruyff RH, Nadeau KC,
Andorf S. Identification of cross-reactive allergens in cashew- and pistachio-allergic
children during oral immunotherapy. Pediatr Allergy Immunol. 2020 Aug;31(6):709-714.
66. Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, O'Mahony L,
Gao Y, Nadeau K, Akdis CA. Immune response to SARS-CoV-2 and mechanisms of
immunopathological changes in COVID-19. Allergy. 2020 Jul;75(7):1564-1581.
67. Andorf S, Bunning B, Tupa D, Cao S, Long AJ, Borres MP, Galli SJ, Chinthrajah RS,
Nadeau KC. Trends in egg specific immunoglobulin levels during natural tolerance and oral
immunotherapy. Allergy. 2020 Jun;75(6):1454-1456.
12
68. Sampath V, Sindher SB, Alvarez Pinzon AM, Nadeau KC. Can food allergy be cured? What
are the future prospects? Allergy. 2020 Jun;75(6):1316-1326.
69. Liu F, Singhal K, Matney R, Acharya S, Akdis CA, Nadeau KC, Chien AS, Leib RD.
Enhancing Data Reliability in TOMAHAQ for Large-Scale Protein Quantification.
Proteomics. 2020 Jun;20(11):e1900105.
70. Luce S, Chinthrajah S, Lyu SC, Nadeau KC, Mascarell L. Th2A and Th17 cell frequencies
and regulatory markers as follow-up biomarker candidates for successful multifood oral
immunotherapy. Allergy. 2020 Jun;75(6):1513-1516. (*co-senior authors)
71. Niespodziana K, Borochova K, Pazderova P, Schlederer T, Astafyeva N, Baranovskaya T,
Barbouche MR, Beltyukov E, Berger A, Borzova E, Bousquet J, Bumbacea RS,
Bychkovskaya S, Caraballo L, Chung KF, Custovic A, Docena G, Eiwegger T, Evsegneeva
I, Emelyanov A, Errhalt P, Fassakhov R, Fayzullina R, Fedenko E, Fomina D, Gao Z,
Giavina-Bianchi P, Gotua M, Greber-Platzer S, Hedlin G, Ilina N, Ispayeva Z, Idzko M,
Johnston SL, Kalayci Ö, Karaulov A, Karsonova A, Khaitov M, Kovzel E, Kowalski ML,
Kudlay D, Levin M, Makarova S, Matricardi PM, Nadeau KC, Namazova-Baranova L,
Naumova O, Nazarenko O, O'Byrne PM, Osier F, Pampura AN, Panaitescu C, Papadopoulos
NG, Park HS, Pawankar R, Pohl W, Renz H, Riabova K, Sampath V, Sekerel BE, Sibanda
E, Siroux V, Sizyakina LP, Sun JL, Szepfalusi Z, Umanets T, Van Bever HPS, van Hage M,
Vasileva M, von Mutius E, Wang JY, Wong GWK, Zaikov S, Zidarn M, Valenta R. Toward
personalization of asthma treatment according to trigger factors. J Allergy Clin Immunol.
2020 Jun;145(6):1529-1534.
72. Celebi Sozener Z, Cevhertas L, Nadeau K, Akdis M, Akdis CA. Environmental factors in
epithelial barrier dysfunction. J Allergy Clin Immunol. 2020 Jun;145(6):1517-1528.
73. Sicherer SH, Warren CM, Dant C, Gupta RS, Nadeau KC. Food Allergy from Infancy
Through Adulthood. J Allergy Clin Immunol Pract. 2020 Jun;8(6):1854-1864.
74. Wright BL, Fernandez-Becker NQ, Kambham N, Purington, N, Cao, S, Tupa, D, Zhang, W,
Sindher, SB, Rank, MA, Kita, H, Katzka, DA, Shim, KP, Bunning, BJ, Doyle, AD,
Jacobsen, EA, Tsai, M, Boyd, SD, Manohar, M, Chinthrajah, RS. Gastrointestinal
Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy.
Clin Gastroenterol Hepatol. 2020 May 17. [Epub ahead of print].
75. Castaño N, Cordts SC, Nadeau KC, Tsai M, Galli SJ, Tang SKY. Microfluidic methods for
precision diagnostics in food allergy. Biomicrofluidics. 2020 Apr 3;14(2):021503.
76. Mathi K, Ataam JA, Kobayashi Y, Amsallem M, Vrtovec B, Martin B, Guihaire J, Fadel E,
Mercier O, Nadeau K, Maecker HT, Haddad F. High Dimensional Flow Cytometry
Characterization of Cardiac Allograft Vasculopathy Highlights Monocyte Activation
Pathways. J Heart Lung Transplant. 2020 Apr;39(4S):S78
77. Dhondalay GKR, Bunning B, Bauer RN, Barnathan ES, Maniscalco C, Baribaud F, Nadeau
KC, Andorf S. Transcriptomic and methylomic features in asthmatic and nonasthmatic
twins. Allergy. 2020 Apr;75(4):989-992.
13
78. Eiwegger T, Anagnostou K, Arasi S, Bégin P, Ben-Shoshan M, Beyer K, Blumchen K,

Brough H, Caubet JC, Chan ES, Chen M, Chinthrajah S, Davis CM, Des Roches A, Du Toit
G, Elizur A, Galli SJ, Håland G, Hoffmann-Sommergruber K, Kim H, Leung DYM, Long A,
Muraro A, Nurmatov UB, Pajno GB, Sampath V, Saxena J, Sindher S, Upton J, Worm M,
Nadeau KC. Conflicting verdicts on peanut oral immunotherapy from the Institute for
Clinical and Economic Review and US Food and Drug Administration Advisory Committee:
Where do we go from here? J Allergy Clin Immunol. 2020 Apr;145(4):1153-1156.
79. DeKruyff RH, Zhang W, Nadeau, KC, Leung DYM, Wills-Karp M. Summary of the
Keystone Symposium “Origins of Allergic Disease: Microbial, Epithelial and Immune
Interactions”, March 24-27, Tahoe City, CA. J Allergy Clin Immunol. 2020
Apr;145(4):1072-1081.
80. Kim JB, Prunicki M, Haddad F, Dant C, Sampath V, Patel R, Smith E, Akdis C, Balmes J,
Snyder MP, Wu JC, Nadeau KC. Cumulative Lifetime Burden of Cardiovascular Disease
From Early Exposure to Air Pollution. J Am Heart Assoc. 2020 Mar 17;9(6):e014944.
81. Hoh RA, Joshi SA, Lee JY, Martin BA, Varma S, Kwok S, Nielsen SCA, Nejad P,
Haraguchi E, Dixit PS, Shutthanandan SV, Roskin KM, Zhang W, Tupa D, Bunning BJ,
Manohar M, Tibshirani R, Fernandez-Becker NQ, Kambham N, West RB, Hamilton RG,
Tsai M, Galli SJ, Chinthrajah RS, Nadeau KC, Boyd SD. Origins and clonal convergence of
gastrointestinal IgE(+) B cells in human peanut allergy. Sci Immunol. 2020 Mar 6;5(45).
82. Balbino B, Herviou P, Godon O, Stackowicz J, Goff OR, Iannascoli B, Sterlin D, Br√ªl√© S,
Millot GA, Harris FM, Voronina VA, Nadeau KC, Macdonald LE, Murphy AJ, Bruhns P,
Reber LL. The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcgamma
receptors. J Clin Invest. 2020 Mar 2;130(3):1330-1335.
83. Tsai M, Mukai K, Chinthrajah RS, Nadeau KC, Galli SJ. Sustained successful peanut oral
immunotherapy associated with low basophil activation and peanut-specific IgE. J Allergy
Clin Immunol. 2020 Mar;145(3):885-896.e6.
84. Neeland MR, Andorf S, Manohar M, Dunham D, Lyu SC, Dang TD, Peters RL, Perrett KP,
Tang MLK, Saffery R, Koplin JJ, Nadeau KC. Mass cytometry reveals cellular fingerprint
associated with IgE+ peanut tolerance and allergy in early life. Nat Commun. 2020 Feb
27;11(1):1091.
85. Tsai M, Chinthrajah S, Nadeau KC. Legends of Allergy: Stephen J. Galli. Allergy. 2020
Jan;75(1):243-245.
86. Chen M, Zhang W, Lee L, Saxena J, Sindher S, Chinthrajah RS, et al. Biologic therapy for
food allergy. Journal of Food Allergy 2020;2:86-90.
87. Bunning BJ, Contrepois K, Lee-McMullen B, Dhondalay GKR, Zhang W, Tupa D, Raeber
O, Desai M, Nadeau KC*, Snyder MP*, Andorf S*. Global metabolic profiling to model
biological processes of aging in twins. Aging Cell. 2019 Jan 19:e13073. (*co-senior authors)
88. Long A, Bunning B, Borro M, Sampath V, Nadeau, KC. The Future of omics for clinical
practice. Ann Allergy Asthma Immunol. 2019 Dec;123(6):535-536.
14
89. Breiteneder H, Diamant Z, Eiwegger T, Fokkens WJ, Traidl-Hoffmann C, Nadeau K,

O’Hehir R, O‘Mahony L, Pfaar O, Torres MJ, Wang DY, Zhang L, Akdis CA. Future trends
in mechanisms and patient care in allergic diseases. Allergy. 2019 Dec;74(12):2293-2311.
90. Chinthrajah S, Cao S, Liu C, Lyu SC, Sindher SB, Long A, Sampath V, Petroni D, Londei
M, Nadeau KC. Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut
allergy. JCI Insight. 2019 Nov 14;4(22).
91. Eiwegger T, Anagnostou K, Arasi S, Bégin P, Ben-Shoshan M, Beyer K, Blumchen K,
Brough H, Caubet JC, Chan ES, Chinthrajah S, Davis CM, Roches AD, Du Toit G, Elizur A,
Galli SJ, Håland G, Hoffmann-Sommergruber K, Kim H, Leung DYM, Muraro A,
Nurmatov UB, Pajno GB, Sindher S, Szepfalusi Z, Torres MJ, Upton J, Worm M, Nadeau
K. ICER report for peanut OIT comes up short. Ann Allergy Asthma Immunol. Ann Allergy
Asthma Immunol. 2019 Nov;123(5):430-432.
92. Kivistö JE, Clarke A, Dery A, De Schryver S, Shand G, Huhtala H, Mäkelä MJ, Asai Y,
Nadeau K, Harada L, Chan ES, Ben-Shoshan M. Genetic and environmental susceptibility to
food allergy in a registry of twins. J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2916-
2918.
93. Du Toit G, Elizur A, Nadeau KC. Cow's Milk and Vitamin D Supplementation in Infants-
Timing Is Everything. JAMA Pediatr. 2019 Oct 21. [Epub ahead of print].
94. Chinthrajah RS, Purington N, Andorf S, Long A, O'Laughlin KL, Lyu SC, Manohar M,
Boyd SD, Tibshirani R, Maecker H, Plaut M, Mukai K, Tsai M, Desai M, Galli SJ*, Nadeau
KC*. Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a
large, randomised, double-blind, placebo-controlled, phase 2 study. Lancet. 2019 Oct
19;394(10207):1437-1449. (* co-senior authors). (Received the 2020 Top 10 Clinical
Research Achievement Award from the Clinical Research Forum, a national forum founded
in 1996 that provides leadership to the national clinical and translational research enterprise
and promotes understanding and support for clinical research and its impact on health and
healthcare).
95. Yadava K, Medina CO, Ishak H, Gurevich I, Kuipers H, Shamskhou EA, Koliesnik IO,
Moon JJ, Weaver C, Nadeau KC, Bollyky PL. Natural Tr1-like cells do not confer long-term
tolerogenic memory. Elife. 2019 Oct 11;8.
96. Prunicki M, Kelsey R, Lee J, Zhou X, Smith E, Haddad F, Wu J, Nadeau K. The impact of
prescribed fire versus wildfire on the immune and cardiovascular systems of children.
Allergy. 2019 Oct;74(10):1989-1991.
97. Che H, Zhang Y, Jiang S, Jin T, Lyu SC, Nadeau KC, McHugh T. Almond (Prunus dulcis)
Allergen Pru du 8, the First Member of a New Family of Food Allergens. J Agric Food
Chem. 2019 Aug 7;67(31):8626-8631.
98. Lee WH, Ong SG, Zhou Y, Tian L, Bae HR, Baker N, Whitlatch A, Mohammadi L, Guo H,
Nadeau KC, Springer ML, Schick SF, Bhatnagar A, Wu JC. Modeling Cardiovascular Risks
of E-Cigarettes with Human Induced Pluripotent Stem Cell-Derived Endothelial Cells. J Am
Coll Cardiol. 2019 Jun 4;73(21):2722-2737.
15
99. Upton J, Montserrat A, Nadeau K. A perspective on the pediatric death from oral food
challenge reported from the Allergy Vigilance Network. Allergy. 2019 Jun;74(6):1035-1036.
100. Yu W, Zhou X, Dunham D, Lyu SC, Manohar M, Zhang W, Zhao F, Davis MM, Nadeau K.
Allergen Specific CD8(+) T cells in Peanut Allergic Individuals. J Allergy Clin Immunol.
2019 May;143(5):1948-1952.
101. Wheatley LM, Wood R, Nadeau K, Liu A, Zoratti E, Bacharier L, Brittain E, Calderon M,
Casale T, Chipps B, Cox L, Creticos PS, Desai M, Dreborg S, Durham S, Gergen PJ,
Gruchalla R, Nelson H, O'Hehir RE, Plaut M, Schwaninger JM, Tilles S, Vickery B,
Wittenberg KM, Togias A. Mind the gaps: clinical trial concepts to address unanswered
questions in aeroallergen immunotherapy. An NIAID/AHRQ Workshop. J Allergy Clin
Immunol. 2019 May;143(5):1711-1726.
102. Howe LC, Leibowitz KA, Perry MA, Bitler JM, Block W, Kaptchuk TJ, Nadeau KC, Crum
AJ. Changing Patient Mindsets About Non-Life-Threatening Symptoms During Oral
Immunotherapy: A Randomized Clinical Trial. J Allergy Clin Immunol Pract. 2019 May -
Jun;7(5):1550-1559.
103. Wang M, Tan G, Eljaszewicz A, Meng Y, Wawrzyniak P, Acharya S, Altunbulakli C,
Westermann P, Dreher A, Yan L, Wang C, Akdis M, Zhang L, Nadeau KC, Akdis CA.
Laundry detergents and detergent residue after rinse directly disrupt tight junction barrier
integrity in human bronchial epithelial cells. J Allergy Clin Immunol. 2019
May;143(5):1892-1903.
104. Emeny RT, Korrick SA, Li Z, Nadeau K, Madan J, Jackson B, Baker E, Karagas MR.
Prenatal exposure to mercury in relation to infant infections and respiratory symptoms in
the New Hampshire Birth Cohort Study. Environ Res. 2019 Apr;171:523-529.
105. Sampath V, Nadeau KC. Newly identified T cell subsets in mechanistic studies of food
immunotherapy. J Clin Invest. 2019 Apr 1;129(4):1431-1440.
106. Davidson WF, Leung DYM, Beck LA, Berin CM, Boguniewicz M, Busse WW, Chatila TA,
Geha RS, Gern JE, Guttman-Yassky E, Irvine AD, Kim BS, Kong HH, Lack G, Nadeau KC,
Schwaninger J, Simpson A, Simpson EL, Spergel JM, Togias A, Wahn U, Wood RA,
Woodfolk JA, Ziegler SF, Plaut M. Report from the National Institute of Allergy and
Infectious Diseases Workshop on "Atopic Dermatitis and the Atopic March: Mechanisms
and Interventions". J Allergy Clin Immunol. 2019 Mar;143(3):894-913.
107. Suarez-Farinas M, Suprun M, Chang HL, Gimenez G, Grishina G, Getts R, Nadeau K,
Wood RA, Sampson HA. Predicting development of "sustained unresponsiveness" to milk
oral immunotherapy using epitope profiles. J Allergy Clin Immunol. 2019 Mar;143(3):1038-
1046.
108. Stranks AJ, Minnicozzi SC, Miller SJ, Burton OT, Logsdon SL, Spergel JM, Nadeau KC,
Pongracic JA, Umetsu DT, Rachid R, MacGinnitie AJ, Schneider L, Oettgen HC. IgE
blockade during food allergen ingestion enhances the induction of inhibitory IgG antibodies.
Ann Allergy Asthma Immunol. 2019 Feb;122(2):213-215.
16
109. Nowak-Węgrzyn A, Wood RA, Nadeau KC, Pongracic JA, Henning AK, Lindblad RW,
Beyer K, Sampson HA. Multicenter, randomized, double-blind, placebo-controlled clinical
trial of vital wheat gluten oral immunotherapy. J Allergy Clin Immunol. 2019
Feb;143(2):651-661.e9.
110. Andorf S*, Purington N*, Kumar D, Long A, O'Laughlin K, Sicherer S, Sampson H,
Cianferoni A, Whitehorn TB, Petroni D, Makhija M, Robison RG, Lierl M, Logsdon S,
Desai M, Galli SJ, Rael E, Assa’ad A*, Chinthrajah S*, Pongracic J*, Spergel JM*, Tam J*,
Tilles S*, Wang J*, Nadeau K*. A Phase 2 randomized controlled multisite study using
omalizumab-facilitated rapid desensitization to test continued vs discontinued dosing in
multifood allergic individuals. Lancet eClinicalMedicine. 2019 Jan; 7:27-48. (* contributed
equally).
111. Che H, Zhang Y, Lyu SC, Nadeau KC, McHugh T. Identification of almond (Prunus dulcis)
vicilin as a food allergen. J Agric Food Chem. 2019 Jan 9;67(1):425-432.
112. Gupta RS, Warren CM, Smith BM, Jiang J, Blumenstock JA, Davis MM, Schleimer RP,
Nadeau KC. Prevalence and Severity of Food Allergies Among US Adults. JAMA Netw
Open. 2019 Jan 4;2(1):e185630.
113. Croote D, Darmanis S, Nadeau KC, Quake SR. High-affinity allergen-specific human
antibodies cloned from single IgE B cell transcriptomes. Science. 2018 Dec
14;362(6420):1306-1309.
114. Gupta RS, Warren CM, Smith BM, Blumenstock JA, Jiang J, Davis MM, Nadeau KC. The
Public Health Impact of Parent-Reported Childhood Food Allergies in the United States.
Pediatrics. 2018 Dec;142(6).
115. Sindher S, Long AJ, Purington N, Chollet M, Slatkin S, Andorf S, Tupa D, Kumar D, Woch
M, O'Laughlin K, Assaad A, Pongracic J, Spergel J, Tam J, Tilles S, Wang J, Galli SJ,
Nadeau KC, Chinthrajah RS. Analysis of a large standardized food challenge data set to
determine predictors of positive outcome across multiple allergens. Front Immunol. 2018
Nov 27;9:2689.
116. Wright BL, Fernandez-Becker NQ, Kambham N, Purington N, Tupa D, Zhang W, Rank
MA, Kita H, Shim KP, Bunning B, Doyle AD, Jacobsen EA, Boyd SD, Tsai M, Maecker H,
Manohar M, Galli SJ*, Nadeau KC*, Chinthrajah RS. Baseline gastrointestinal eosinophilia
is common in oral immunotherapy subjects with IgE-mediated peanut allergy. Front
Immunol. 2018 Nov 22;9:2624. (* co-senior authors).
117. Rathore DK, Holmes TH, Nadeau KC, Mittal P, Batra A, Rosenberg-Hasson Y, Sopory S,
Gupta R, Chellani HK, Aggarwal KC, Bal V, Natchu UCM, Bhatnagar S, Tavassoli M, Lyell
DJ, Rath S, Wadhwa N, Maecker HT. Differences in multiple immune parameters between
Indian and U.S. infants. PLoS One. 2018 Nov 16;13(11):e0207297.
118. Birrueta G, Tripple V, Pham J, Manohar M, James E, Kwok WW, Nadeau K, Sette A, Peters
B, Schulten V. Peanut-specific T cell responses in patients with different clinical reactivity.
PLoS One. 2018 Oct 10;13(10):e0204620.
17
119. Sindher SB, Long A, Acharya S, Sampath V, Nadeau KC. The use of biomarkers to predict
aero-allergen and food immunotherapy responses. Clin Rev Allergy Immunol. 2018
Oct;55(2):190-204.
120. Purington N, Chinthrajah RS, Long A, Sindher S, Andorf S, O'Laughlin K, Woch MA,
Scheiber AJ, Assa’ad A, Pongracic J, Spergel J, Tam J, Tilles S, Wang J, Galli SJ, Desai M,
Nadeau KC. Eliciting Dose and Safety Outcomes From a Large Dataset of Standardized
Multiple Food Challenges. Front Immunol. 2018 Sep 21;9:2057.
121. Zhang W, Sindher S, Sampath V, Nadeau KC. Comparison of Sublingual Immunotherapy and
Oral Immunotherapy in Peanut Allergy. Allergo J Int. 2018 September; 27(6):153-161.
122. Chinthrajah RS, Purington N, Andorf S, Rosa JS, Mukai K, Hamilton R, Smith BM, Gupta R,
Galli SJ, Desai M, Nadeau KC. Development of a Tool Predicting Severity of Allergic
Reaction During Peanut Challenge. Ann Allergy Asthma Immunol. 2018 Jul;121(1):69-76.e2.
123. Chinthrajah RS, Purington N, Sampath V, Andorf S, Manohar M, Prunicki M, Zhou X, Tupa
D, Nadeau KC. High dimensional immune biomarkers demonstrate differences in phenotypes
and endotypes in food allergy and asthma. Ann Allergy Asthma Immunol. 2018
Jul;121(1):117-119.e1.
124. Rice MB, Malea NM, Pinkerton KE, Schwartz J, Nadeau KC, Browner CM, Whitehouse S,
Thurston GD. Realizing the Paris Climate Agreement to Improve Cardiopulmonary Health:
Where Science Meets Policy. Ann Am Thorac Soc. 2018 Jul;15(7):791-798.
125. Renand A, Farrington M, Whalen E, Wambre E, Bajzik V, Chinthrajah S, Nadeau KC, Kwok
WW. Heterogeneity of Ara h Component-Specific CD4 T Cell Responses in Peanut-Allergic
Subjects. Front Immunol. 2018 Jun 25;9:1408.
126. Zhang W, Lin C, Sampath V, Nadeau K. Impact of allergen immunotherapy in allergic
asthma. Immunotherapy. 2018 Jun;10(7):579-593.
127. Tsai CT, Mukai K, Robinson PV, Gray MA, Waschmann MB, Lyu SC, Tsai M,
Chinthrajah RS, Nadeau KC, Bertozzi CR, Galli SJ. Isotype-Specific Agglutination- PCR
(ISAP): a sensitive and multiplex method for measuring allergen-specific IgE. J Allergy Clin
Immunol. 2018 May;141(5):1901-1904.e15.
128. Pajno GB, Fernandez-Rivas M, Arasi S, Roberts G, Akdis CA, Alvaro-Lozano M, Beyer
K, Bindslev-Jensen C, Burks W, Ebisawa M, Eigenmann P, Knol E, Nadeau KC, Poulsen
LK, van Ree R, Santos AF, du Toit G, Dhami S, Nurmatov U, Boloh Y, Makela M,
O'Mahony L, Papadopoulos N, Sackesen C, Agache I, Angier E, Halken S, Jutel M, Lau S,
Pfaar O, Ryan D, Sturm G, Varga EM, van Wijk RG, Sheikh A, Muraro A; EAACI
Allergen Immunotherapy Guidelines Group. EAACI Guidelines on allergen immunotherapy:
IgE-mediated food allergy. Allergy. 2018 Apr;73(4):799-815.
129. Sampath V, Sindher SB, Zhang W, Nadeau KC. New treatment directions in food allergy. Ann
Allergy Asthma Immunol. 2018 Mar;120(3):254-262.
18
130. Andorf A, Purington N, Block W, Long A, Tupa D, Brittain E, Spergel A, Desai M, Galli S,
Nadeau K, Chinthrajah S. Anti-IgE Treatment with Oral Immunotherapy in Multifood
Allergic Patients. Lancet Gastroenterol Hepatol. 2018 Feb;3(2):85-94.
131. Prunicki M, Stell L, Dinakarpandian D, de Planell-Saguer M, Lucas RW, Hammond SK,
Balmes JR, Zhou X, Paglino T, Sabatti C, Miller RL, Nadeau KC. Exposure to NO2, CO,
and PM2.5 is linked to regional DNA methylation differences in asthma. Clin Epigenetics.
2018 Jan 5;10:2. 2018.
132. Dhondalay GK, Rael E, Acharya, S, Zhang W, Sampath V, Galli SJ, Tibshirani, R, Boyd
SD, Maecker, H, Nadeau KC, Andorf S. Food allergy and omics. J Allergy Clin
Immunol. 2018 Jan;141:20-29.
133. Pellerin L, Jenks JA, Chinthrajah S, Dominguez T, Block W, Zhou X, Noshirvan A, Gregori
S, Roncarolo MG, Bacchetta R*, Nadeau KC*. Peanut-specific type 1 regulatory cells
induced in vitro from allergic subjects are functionally impaired. J Allergy Clin Immunol.
2018 Jan;141(1):202-213.e8. (* co-senior authors).
134. Andorf S, Manohar M, Dominguez T, Block W, Tupa D, Kshirsagar RA, Sampath V,
Chinthrajah RS*, Nadeau KC*. Feasibility of sustained response through long-term dosing
in food allergy immunotherapy. Allergy Asthma Clin Immunol. 2017 Dec 21;13:52.
2017. (* co-senior authors).
135. Andorf S*, Manohar M*, Dominguez T, Block W, Tupa D, Kshirsagar RA, Sampath V,
Chinthrajah RS**, Nadeau KC**. Observational long-term follow-up study of rapid food
oral immunotherapy with omalizumab. Allergy Asthma Clin Immunol. 2017 Dec 21;13:51.
2017. (* contributed equally, ** co-senior authors).
136. Sampson HA, Shreffler WG, Yang WH, Sussman GL, Brown-Whitehorn TF, Nadeau KC,
Cheema AS, Leonard SA, Pongracic JA, Sauvage-Delebarre C, Assa'ad AH, de Blay F, Bird
JA, Tilles SA, Boralevi F, Bourrier T, Hébert J, Green TD, Gerth van Wijk R, Knulst AC,
Kanny G, Schneider LC, Kowalski ML, Dupont C. Effect of Varying Doses of
Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among
Patients With Peanut Sensitivity: A Randomized Clinical Trial. JAMA. 2017 Nov
14;318(18):1798-1809.
137. Lin C, Lee IT, Sampath V, Dinakar C, DeKruyff RH, Schneider LC, Nadeau KC. Combining
anti-IgE with oral immunotherapy. Pediatr Allergy Immunol. 2017 Nov;28(7):619-627.
138. Boyd S, Hoh R, Nadeau K, Galli S. Immune Monitoring for Precision Medicine in Allergy
and Asthma. Curr Opin Immunol. 2017 Oct;48:82-91.
139. Mukai K, Chinthrajah RS, Nadeau KC, Tsai M, Gaudenzio N, Galli SJ. A new fluorescent-
avidin-based method for quantifying basophil activation in whole blood. J Allergy Clin
Immunol. 2017 Oct;140(4):1202-1206.e3.
140. Frischmeyer-Guerrerio PA, Masilamani M, Gu W, Brittain E, Wood R, Kim J, Nadeau
K, Jarvinen KM, Grishin A, Lindblad R, Sampson HA. Mechanistic correlates of clinical
responses to omalizumab in the setting of oral immunotherapy for milk allergy. J Allergy
Clin Immunol. 2017 Oct;140(4):1043-1053.e8.
19
141. Andorf S, Borres MP, Block W, Tupa D, Bollyky JB, Sampath V, Elizur A, Lidholm J, Jones
JE, Galli SJ, Chinthrajah S, Nadeau KC. Association of clinical reactivity with sensitization
to allergen components in multifood-allergic children. J Allergy Clin Immunol Pract. 2017
Sep - Oct;5(5):1325-1334.
142. Nurmatov U, Dhami S, Arasi S, Pajno GB, Fernandez-Rivas M, Muraro A, Roberts G, Akdis
C, Alvaro-Lozano M, Beyer K, Bindslev-Jensen C, Burks W, du Toit G, Ebisawa M,
Eigenmann P, Knol E, Makela M, Nadeau KC, O'Mahony L, Papadopoulos N, Poulsen LK,
Sackesen C, Sampson H, Santos A, van Ree R, Timmermans F, Sheikh A. Allergen
immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis.
Allergy. 2017 Aug;72(8):1133-1147.
143. Chang, H, Nadeau KC. IL-4Rα Inhibitor for Atopic Disease. Cell. 2017 Jul 13;170(2):222.
144. Park HK, Cheng KC, Tetteh AO, Hildemann LM, Nadeau KC. Effectiveness of air purifier
on health outcomes and indoor particles in homes of children with allergic diseases in
Fresno, California: A pilot study. J Asthma. 2017 May;54(4):341-346.
145. Muraro A, Lemanske RF Jr, Castells M, Torres MJ, Khan D, Simon HU, Bindslev- Jensen
C, Burks W, Poulsen LK, Sampson HA, Worm M, Nadeau KC. Precision Medicine in
Allergic Disease – Food Allergy, Drug Allergy, and Anaphylaxis- PRACTALL document of
the European Academy of Allergy and Clinical Immunology and the American Academy of
Allergy, Asthma & Immunology. Allergy. 2017 Jul;72(7):1006-1021.
146. Nygaard UC, Li Z, Palys T, Jackson B, Subbiah M, Malipatlolla M, Sampath V,
Maecker H, Karagas MR*, Nadeau KC*.. Cord blood T cell subpopulations and
associations with maternal cadmium and arsenic exposures. PLoS One. 2017 Jun
29;12(6):e0179606. (* co-senior authors).
147. Lee EY, Lin J, Noth EM, Hammond SK, Nadeau KC, Eisen EA, Balmes JR. Traffic-
Related Air Pollution and Telomere Length in Children and Adolescents Living in Fresno,
CA: A Pilot Study. J Occup Environ Med. 2017 May;59(5):446-452.
148. Otani I.M., Nadeau K.C. Biological Therapies for Immunoglobulin E-mediated Food
Allergy and Eosinophilic Esophagitis. Immunol Allergy Clin North Am. 2017
May;37(2):369-396.
149. Breton, C.V., Marsit, C.J., Faustman, E., Nadeau, K., Goodrich, J.M., Dolinoy, D.C.,
Herbstman, J., Holland, N., LaSalle, J.M., Schmidt, R., Yousefi, P., Perera, F., Joubert,
B.R., Wiemels, J., Taylor, M., Yang, I.V., Chen, R., Hew, K.M., Hussey Freeland,
D.M.,Miller, R. and S.K. Murphy. Small Magnitude Effect Sizes in Epigenetic Endpoints
are Important in Children's Environmental Health Studies: The Children's Environmental
Health and Disease Prevention Research Center's Epigenetics Working Group.
Environmental Health Perspectives. 2017 Apr;125(4):511-526.
150. Freeland DMH, Manohar M, Andorf S, Hobson BD, Zhang W, Nadeau KC. Oral
immunotherapy for food allergy. Semin Immunol. 2017 Apr;30:36-44.
151. MacGinnitie AJ, Rachid R, Gragg H, Little SV, Lakin P, Cianferoni A, Heimall J, Makhija M,
Robison R, Chinthrajah RS, Lee J, Lebovidge J, Dominguez T, Rooney C, Lewis MO, Koss J,
20
Burke-Roberts E, Chin K, Logvinenko T, Pongracic JA, Umetsu DT, Spergel J*, Nadeau KC*,
Schneider LC*. Omalizumab facilitates rapid oral desensitization for peanut allergy. J Allergy
Clin Immunol. 2017 Mar;139(3):873-881.e8. (* co senior authors)
152. Ahuja SK, Manoharan MS, Harper NL, Jimenez F, Hobson BD, Martinez H, Ingale P, Liu
YG, Carrillo A, Lou Z, Kellog DL, Ahuja SS, Rather CG, Esch RE, Ramirez DA, Clark
RA, Nadeau K, Andrews CP, Jacobs RL, He W. Preservation of epithelial cell barrier
function and muted inflammation in resistance to allergic rhinoconjunctivitis from house
dust mite challenge. J Allergy Clin Immunol. 2017 Mar;139(3):844-854.
153. Mukai K, Gaudenzio N, Gupta S, Vivanco N, Bendall SC, Maecker HT, Chinthrajah RS,
Tsai M, Nadeau KC, Galli SJ. Assessing basophil activation by using flow cytometry
and mass cytometry in blood stored 24 hours before analysis. J Allergy Clin Immunol. 2017
Mar;139(3):889-899.e11.
154. Zhang YZ, Du WX, Fan Y, Yi J, Lyu SC, Nadeau KC, Thomas AL, McHugh T.
Purification and Characterization of a Black Walnut (Juglans nigra) Allergen, Jug n 4. J
Agric Food Chem. 2017 Jan 18;65(2):454-462.
155. Gebe JA, Yadava K, Ruppert SM, Marshall P, Hill P, Falk BA, Sweere JM, Han H, Kaber
G, Medina C, Mikecz K, Ziegler SF, Balaji S, Keswani SG, de Jesus Perez VA, Butte MJ,
Nadeau K, Altemeier WA, Fanger N, Bollyky PL. Modified High Molecular Weight
Hyaluronan Promotes Allergen-Specific Immune Tolerance. Am J Respir Cell Mol Biol.
2017 Jan;56(1):109-120.
156. Sampath V, Tupa D, Graham MT, Chatila TA, Spergel JM, Nadeau KC. Deciphering the
black box of food allergy mechanisms. Ann Allergy Asthma Immunol. 2017
Jan;118(1):21-27.
157. Zhang Y, Du WX, Fan Y, Yi J, Lyu SC, Nadeau KC, McHugh TH. Identification,
characterization, and initial epitope mapping of pine nut allergen Pin k 2. Food Res Int.
2016 Dec;90:268-274.
158. Yu W, Freeland DM, Nadeau KC. Food allergy: immune mechanisms, diagnosis and
immunotherapy. Nat Rev Immunol. 2016 Dec;16(12):751-765.
159. Bunning BJ, DeKruyff RH, Nadeau KC. Epigenetic Changes During Food-Specific
Immunotherapy. Curr Allergy Asthma Rep. 2016 Nov;16(12):87.
160. Graham MT, Andorf S, Spergel JM, Chatila TA, Nadeau KC. Temporal Regulation by
Innate Type 2 Cytokines in Food Allergies. Curr Allergy Asthma Rep. 2016
Oct;16(10):75.
161. Hussey Freeland DM, Fan-Minogue H, Spergel JM, Chatila TA, Nadeau KC. Advances in
food allergy oral immunotherapy: toward tolerance. Curr Opin Immunol. 2016 Oct;42:119-
123.
162. Dhami S, Nurmatov U, Pajno GB, Fernandez-Rivas M, Muraro A, Roberts G, Akdis C,
Alvaro-Lozano M, Beyer K, Bindslev-Jensen C, Burks W, du Toit G, Ebisawa M,
Eigenmann P, Knol E, Makela M, Nadeau KC, O'Mahony L, Papadopoulos N, Poulsen
L, Sackesen C, Sampson H, Santos A, van Ree R, Timmermans F, Sheikh A. Allergen
21
immunotherapy for IgE-mediated food allergy: protocol for a systematic review. Clin
Transl Allergy. 2016 Jul 5;6:24.
163. Ng E, Nadeau KC, Wang S. Giant magnetoresistive sensor array for sensitive and specific
multiplexed food allergen detection. Biosens Bioelectron. 2016 Jun 15;80:359-65.
164. Cheng KC, Park HK, Tetteh AO, Zheng D, Ouellette NT, Nadeau KC, Hildemann LM.
Mixing and sink effects of air purifiers on indoor PM2.5 concentrations: A pilot study of
eight residential homes in Fresno, California. Aerosol Sci and Technol. 2016, June; Vol. 50,
Iss. 8.
165. Farzan SF, Li Z, Korrick SA, Spiegelman D, Enelow R, Nadeau K, Baker E, Karagas MR.
Infant Infections and Respiratory Symptoms in Relation to in Utero Arsenic Exposure in
a U.S. Cohort. Environ Health Perspect. 2016 Jun;124(6):840-7.
166. Zhang Y, Lee B, Du WX, Lyu SC, Nadeau KC, Grauke LJ, Zhang Y, Wang S, Fan Y, Yi J,
McHugh TH. Identification and Characterization of a New Pecan [Carya illinoinensis
(Wangenh.) K. Koch] Allergen, Car i 2. J Agric Food Chem. 2016 May 25;64(20):4146-51.
167. Bégin P, Winterroth LC, Dominguez T, Wilson SP, Bacal L, Mehrotra A, Kausch B, Trela
A, Hoyte E, O'Riordan G, Seki S, Blakemore A, Woch M, Hamilton RG, Nadeau KC.
Erratum to: Safety and feasibility of oral immunotherapy to multiple allergens for food
allergy. Allergy Asthma Clin Immunol. 2016 May 24;12:28.
168. Pennington L, Tarchevskaya S, Brigger D, Sathiyamoorthy K, Graham MT, Nadeau KC,
Eggel A, Jardetzky T. Structural basis of omalizumab therapy and omalizumab mediated
IgE exchange. Nat Commun. 2016 May 19;7:11610.
169. Wood RA, Kim JS, Lindblad R, Nadeau K, Henning AK, Dawson P, Plaut M,
Sampson HA. A randomized, double-blind, placebo-controlled study of omalizumab
combined with oral immunotherapy for the treatment of cow's milk allergy. J Allergy Clin
Immunol. 2016 Apr;137(4):1103-1110.
170. Chinthrajah RS, Hernandez JD, Boyd SD, Galli SJ*, Nadeau KC*. Molecular and
cellular mechanisms of food allergy and food tolerance. J Allergy Clin Immunol. 2016
Apr;137(4):984-97. (* co-senior authors).
171. Ryan JF*, Hovde R*, Glanville J*, Lyu SC, Ji X, Gupta S, Tibshirani RJ, Jay DC, Boyd SD3,
Chinthrajah RS, Davis MM, Galli SJ, Maecker HT, Nadeau KC. Successful immunotherapy
induces previously unidentified allergen-specific CD4+ T-cell subsets. Proc Natl Acad Sci U S
A. 2016 Mar 1;113(9):E1286-95. (contributed equally)
172. Bauer RN*, Chinthrajah RS*, Andorf S, Hobson B, Miller RL, Nadeau KC. T-Cell
Immunophenotyping of Second-Hand Smoke-related Asthma. Ann Am Thorac Soc. 2016
Mar;13 Suppl 1:S95. (* contributed equally)
173. Hoh RA, Joshi SA, Liu Y, Wang C, Roskin KM, Lee JY, Pham T, Looney TJ, Jackson KJ,
Dixit VP, King J, Lyu SC, Jenks J, Hamilton RG, Nadeau KC, Boyd SD. Single B-cell
deconvolution of peanut-specific antibody responses in allergic patients. J Allergy Clin
Immunol. 2016 Jan;137(1):157-67.
22
174. Ma J, Strub P, Lv N, Xiao L, Camargo CA Jr, Buist AS, Lavori PW, Wilson SR, Nadeau
KC, Rosas LG. Pilot randomised trial of a healthy eating behavioural intervention in
uncontrolled asthma. Eur Respir J. 2016 Jan;47(1):122-32.
175. Cheng K-C, Zheng D, Tetteh AO, Park H-K, Nadeau KC & Hildemann LM. Personal
exposure to airborne particulate matter due to residential dryer lint cleaning. Building and
Environment. 2016. 98:145-149.
176. Chinthrajah RS, Tupa D, Prince BT, Block WM, Rosa JS, Singh AM, Nadeau K.
Diagnosis of Food Allergy. Pediatr Clin North Am. 2015 Dec;62(6):1393-408.
177. Prince BT, Mandel MJ, Nadeau K, Singh AM. Gut Microbiome and the Development of
Food Allergy and Allergic Disease. Pediatr Clin North Am. 2015 Dec;62(6):1479- 92.
178. Levy BD, Noel PJ, Freemer MM, Cloutier MM, Georas SN, Jarjour NN, Ober C,
Woodruff PG, Barnes KC, Bender BG, Camargo CA Jr, Chupp GL, Denlinger LC, Fahy
JV, Fitzpatrick AM, Fuhlbrigge A, Gaston BM, Hartert TV, Kolls JK, Lynch SV, Moore
WC, Morgan WJ, Nadeau K, Ownby DR, Solway J, Szefler SJ, Wenzel SE, Wright RJ,
Smith RA, Erzurum SC. Future Research Directions in Asthma: An NHLBI Working Group
Report. Am J Respir Crit Care Med. 2015 Dec 1;192(11):1366-72.
179. Walter JE, Rosen LB, Csomos K, Rosenberg JM, Mathew D, Keszei M, Ujhazi B, Chen
K, Lee YN, Tirosh I, Dobbs K, Al-Herz W, Cowan MJ, Puck J, Bleesing JJ, Grimley MS,
Malech H, De Ravin SS, Gennery AR, Abraham RS, Joshi AY, Boyce TG, Butte MJ,
Nadeau KC, Balboni I, Sullivan KE, Akhter J, Adeli M, El-Feky RA, El-Ghoneimy DH,
Dbaibo G, Wakim R, Azzari C, Palma P, Cancrini C, Capuder K, Condino-Neto A, Costa-
Carvalho BT, Oliveira JB, Roifman C, Buchbinder D, Kumanovics A, Franco JL, Niehues
T, Schuetz C, Kuijpers T, Yee C, Chou J, Masaad MJ, Geha R, Uzel G, Gelman R,
Holland SM, Recher M, Utz PJ, Browne SK, Notarangelo LD. Broad-spectrum
antibodies against self-antigens and cytokines in RAG deficiency. J Clin Invest. 2015 Nov
2;125(11):4135-48.
180. Bégin P, Schulze J, Baron U, Olek S, Bauer RN, Passerini L, Baccheta R, Nadeau KC.
Human in vitro induced T regulatory cells and memory T cells share common
demethylation of specific FOXP3 promoter region. Clin Transl Allergy. 2015 Oct 20;5:35.
181. Quake C and Nadeau K. The Role of Epigenetic Mediation and the Future of Food Allergy
Research. Semin Cell Dev Biol. 2015 Jul;43:125-30.
182. Roskin KM, Simchoni N, Liu Y, Lee JY, Seo K, Hoh RA, Pham T, Park JH, Furman D,
Dekker CL, Davis MM, James JA, Nadeau KC, Cunningham-Rundles C, Boyd SD. IgH
sequences in common variable immune deficiency reveal altered B cell development and
selection. Sci Transl Med. 2015 Aug 26;7(302):302ra135.
183. Mathieu AL, Verronese E, Rice GI, Fouyssac F, Bertrand Y, Picard C, Chansel M, Walter
JE, Notarangelo LD, Butte MJ, Nadeau KC, Csomos K, Chen DJ, Chen K, Delgado A,
Rigal C, Bardin C, Schuetz C, Moshous D, Reumaux H, Plenat F, Phan A, Zabot MT,
Balme B, Viel S, Bienvenu J, Cochat P, van der Burg M, Caux C, Kemp EH, Rouvet I,
Malcus C, Méritet JF, Lim A, Crow YJ, Fabien N, Ménétrier-Caux C, De Villartay JP,
Walzer T, Belot A. PRKDC mutations associated with immunodeficiency, granuloma, and
23
autoimmune regulator-dependent autoimmunity. J Allergy Clin Immunol. 2015

Jun;135(6):1578-88.e5.
184. Sabounchi S, Bollyky J, Nadeau K. Review of Environmental Impact on the Epigenetic
Regulation of Atopic Diseases. Curr Allergy Asthma Rep. 2015 Jun;15(6):33.
185. Begin P and Nadeau KC. Changes in peanut-specific T-cell clonotype with oral
immunotherapy. J Allergy Clin Immunol. 2015 Apr 27. (15) 408-410.
186. Hong X*, Hao K*, Ladd-Acosta C*, Hansen KD, Tsai HJ, Liu X, Xu X, Thornton TA,
Caruso D, Keet CA, Sun Y, Wang G, Luo W, Kumar R, Fuleihan R, Singh AM, Kim JS,
Story RE, Gupta RS, Gao P, Chen Z, Walker SO, Bartell TR, Beaty TH, Fallin MD,
Schleimer R, Holt PG, Nadeau KC, Wood RA, Pongracic JA, Weeks DE, Wang X. Genome-
wide association study identifies peanut allergy-specific loci and evidence of epigenetic
mediation in US children. Nat Commun. 2015 Feb 24;6:6304. (* contributed equally).
187. Bauer RN, Manohar M, Singh AM, Jay DC, Nadeau KC. The future of biologics:
applications for food allergy. J Allergy Clin Immunol. 2015 Feb;135(2):312-23.
188. Pajno GB, Nadeau KC, Passalacqua G, Caminiti L, Hobson B, Jay DC, Arasi S,Chiera F,
Salzano G. The evolution of allergen and non-specific immunotherapy: past achievements,
present applications and future outlook. Expert Rev Clin Immunol. 2015 Jan;11(1):141-
54.
189. Hew KM, Walker AI, Kohli A, Garcia M, Syed A, McDonald-Hyman C, Noth EM, Mann
JK, Pratt B, Balmes J, Hammond SK, Eisen EA*, Nadeau KC*. Childhood exposure to
ambient polycyclic aromatic hydrocarbons is linked to epigenetic modifications and
impaired systemic immunity in T cells. Clin Exp Allergy. 2015 Jan;45(1):238-48. (* co-
senior authors).
190. Haraksingh RR, Jahanbani F, Rodriguez-Paris J, Gelernter J, Nadeau KC, Oghalai JS,
Schrijver I, Snyder MP. Exome sequencing and genome-wide copy number variant
mapping reveal novel associations with sensorineural hereditary hearing loss. BMC
Genomics. 2014 Dec 20;15:1155.
191. Nadeau KC, Li Z, Farzan S, Koestler D, Robbins D, Fei DL, Malipatlolla M, Maecker H,
Enelow R, Korrick S, Karagas MR. In utero arsenic exposure and fetal immune repertoire in a
US pregnancy cohort. Clin Immunol. 2014 Dec;155(2):188-97.
192. Graham MT and Nadeau KC. Lessons learned from mice and man: mimicking human allergy
through mouse models. Clin Immunol. 2014 Nov;155(1):1-16.
193. Cho KS, Soudry E, Psaltis AJ, Nadeau KC, McGhee SA, Nayak JV, Hwang PH. Long- term
sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease.
Otolaryngol Head Neck Surg. 2014 Oct;151(4):575-81.
194. Sleiman PM, Wang ML, Cianferoni A, Aceves S, Gonsalves N, Nadeau K, Bredenoord
AJ, Furuta GT, Spergel JM, Hakonarson H. GWAS identifies four novel eosinophilic
esophagitis loci. Nat Commun. 2014 Nov 19;5:5593.
195. Sampson H, Aceves S, Bock A, James J, Jones S, Lang D, Nadeau KC, Nowak-
Wegrzyn A, Oppenheimer J, Perry T, Randolph C, Sicherer S, Simon R, Vickery B, and
24
Wood R. Food Allergy: A practice parameter update-2014. J Allergy Clin Immunol.

2014 Nov;134(5):1016-25.e43.
196. Arasi S, Otani IM, Klingbeil E, Bégin P, Kearney C, Dominguez TL, Block WM,
O'Riordan G, Nadeau KC. Two year effects of food allergen immunotherapy on quality of
life in caregivers of children with food allergies. Allergy Asthma Clin Immunol. 2014 Nov
25;10(1):57.
197. Manohar M and Nadeau KC. The Potential of Anti-IgE in Food Allergy Therapy. Curr Treat
Options Allergy. 2014 Jun 1;1(2):145-156.
198. Jay DC and Nadeau KC. Immune mechanisms of sublingual immunotherapy. Curr Allergy
Asthma Rep. 2014 Nov;14(11):473.
199. Syed A, Hew K, Kohli A, Knowlton G, Nadeau KC. Air Pollution and Epigenetics. J
Environ Prot. 2013. 4, 114-122.
200. Lv N, Xiao L, Camargo CA Jr, Wilson SR, Buist AS, Strub P, Nadeau KC, Ma J.
Abdominal and general adiposity and level of asthma control in adults with uncontrolled
asthma. Ann Am Thorac Soc. 2014 Oct;11(8):1218-24.
201. Rothenberg ME, Wen T, Greenberg A, Alpan O, Enav B, Hirano I, Nadeau K, Kaiser S,
Peters T, Perez A, Jones I, Arm JP, Strieter RM, Sabo R, Gunawardena KA.
Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allergy
Clin Immunol. 2015 Feb;135(2):500-7.
202. Alexander ES, Martin LJ, Collins MH, Kottyan LC, Sucharew H, He H, Mukkada VA, Succop
PA, Abonia JP, Foote H, Eby MD, Grotjan TM, Greenler AJ, Dellon ES, Demain JG, Furuta
GT, Gurian LE, Harley JB, Hopp RJ, Kagalwalla A, Kaul A, Nadeau KC, Noel RJ, Putnam
PE, von Tiehl KF, Rothenberg ME. Twin and family studies reveal strong environmental and
weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin
Immunol. 2014 Nov;134(5):1084-1092.e1.
203. Padula AM, Balmes JR, Eisen EA, Mann J, Noth EM, Lurmann FW, Pratt B, Tager IB,
Nadeau K, Hammond SK. Ambient polycyclic aromatic hydrocarbons and pulmonary
function in children. J Expo Sci Environ Epidemiol. 2014 Jun 18.
204. McKenzie RB, Berquist WE, Nadeau KC, Louie CY, Chen SF, Sibley RK, Glader BE,
Wong WB, Hofmann LV, Esquivel CO, Cox KL. Novel protocol including liver biopsy to
identify and treat CD8+ T-cell predominant acute hepatitis and liver failure. Pediatr
Transplant. 2014 Aug;18(5):503-09.
205. Begin P, Chinthrajah RS, Nadeau KC. Oral immunotherapy for the treatment of food allergy.
Hum Vaccin Immunother. 2014 Jun 5;10(8):2295-302.
206. Klingbeil EC, Hew KM, Nygaard UC, Nadeau KC. Polycyclic aromatic hydrocarbons,
tobacco smoke, and epigenetic remodeling in asthma. Immunol Res. 2014 May;58(2-
3):369-73.
207. Pellerin L, Jenks JA, Bégin P, Bacchetta R, Nadeau KC. Regulatory T cells and their roles in
immune dysregulation and allergy. Immunol Res. 2014 May;58(2-3):358-68.
25
208. Jones PP and Nadeau KC. Introduction to the special issue on Stanford Immunology. Immunol
Res. 2014 May;58(2-3):161-3.
209. Otani IM, Bégin P, Kearney C, Dominguez TL, Mehrotra A, Bacal LR, Wilson S, Nadeau
KC. Multiple-allergen oral immunotherapy improves quality of life in caregivers of food-
allergic pediatric subjects. Allergy Asthma Clin Immunol. 2014 May 12;10(1):25.
210. Begin P and Nadeau KC. Bégin P, Nadeau KC. Epigenetic regulation of asthma and allergic
disease. Allergy Asthma Clin Immunol. 2014 May 28;10(1):27.
211. Syed A, Garcia MA, Lyu SC, Bucayu R, Kohli A, Ishida S, Berglund JP, Tsai M,
Maecker H, O'Riordan G, Galli SJ, Nadeau KC. Peanut oral immunotherapy results in
increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box
protein 3 (FOXP3). J Allergy Clin Immunol. 2014 Feb;133(2):500-10.
212. Bégin P, Dominguez T, Wilson SP, Bacal L, Mehrotra A, Kausch B, Trela A,
Tavassoli M, Hoyte E, O'Riordan G, Blakemore A, Seki S, Hamilton RG, Nadeau KC.
Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to
multiple foods using Omalizumab. Allergy Asthma Clin Immunol. 2014 Feb 20;10(1):7.
213. Bégin P, Winterroth LC, Dominguez T, Wilson SP, Bacal L, Mehrotra A, Kausch B, Trela
A, Hoyte E, O'Riordan G, Seki S, Blakemore A, Woch M, Hamilton RG, Nadeau KC. Safety
and feasibility of oral immunotherapy to multiple allergens for food allergy. Allergy
Asthma Clin Immunol. 2014 Jan 15;10(1):1.
214. Kanai T, Seki S, Jenks JA, Kohli A, Kawli T, Martin DP, Snyder M, Bacchetta R, Nadeau KC.
Identification of STAT5A and STAT5B target genes in human T cells PLoS One. 2014 Jan
30;9(1):e86790.
215. Syed A, Kohli A, Nadeau KC. Food allergy diagnosis and therapy: where are we now?
Immunotherapy. 2013 Sep; 5(9):931-44.
216. Iyengar SR, Hoyte EG, Loza A, Bonaccorso S, Chiang D, Umetsu DT, Nadeau KC.
Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a
randomized, placebo-controlled clinical trial. Int Arch Allergy Immunol. 2013;162(1):89-
93.
217. Jenks JA, Seki S, Kanai T, Huang J, Morgan AA, Scalco RC, Nath R, Bucayu R, Wit JM,
Al-Herz W, Ramadan D, Jorge AA, Bacchetta R, Hwa V, Rosenfeld R, Nadeau KC.
Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. Clin Immunol.
2013 Aug;148(2):227-36.
218. Dominguez TL, Bégin P, Nadeau KC. The use of epinephrine in acute allergic
reaction to food. Pediatr Ann. 2013 Jul;42(7):293-5.
219. Chen R, Giliani S, Lanzi G, Mias GI, Lonardi S, Dobbs K, Manis J, Im H, Gallagher JE,
Phanstiel DH, Euskirchen G, Lacroute P, Bettinger K, Moratto D, Weinacht K, Montin D,
Gallo E, Mangili G, Porta F, Notarangelo LD, Pedretti S, Al-Herz W, Alfahdli W,
Comeau AM, Traister RS, Pai SY, Carella G, Facchetti F, Nadeau KC, Snyder M,
Notarangelo LD. Whole-exome sequencing identifies tetratricopeptide repeat domain 7A
26
(TTC7A) mutations for combined immunodeficiency with intestinal atresias. J Allergy Clin
Immunol. 2013 Sep;132(3):656-664.
220. Reber LL, Marichal T, Mukai K, Kita Y, Tokuoka SM, Roers A, Hartmann K, Karasuyama H,
Nadeau KC, Tsai M, Galli SJ. Selective ablation of mast cells or basophils reduces peanut-
induced anaphylaxis in mice. J Allergy Clin Immunol. 2013 Oct;132(4):881-8.
221. Ma J, Strub P, Lavori PW, Buist AS, Camargo CA Jr, Nadeau KC, Wilson SR, Xiao L. DASH
for asthma: A pilot study of the DASH diet in not-well-controlled adult asthma. Contemp Clin
Trials. 2013 Jul;35(2):55-67.
222. Liu, J, Zhang, L, Winterroth, L, Garcia, M, Weiman, S, Wong, J, Sunwoo, J, Nadeau, KC.
Epigenetically-mediated pathogenic effects of phenanthrene on regulatory T cells. J
Toxicol. 2013; 967- 981.
223. Le-Carlson M, Seki S, Abarbanel D, Quiros A, Cox K, Nadeau KC. Markers of antigen
presentation and activation on eosinophils and T-cells in the esophageal tissue of patients with
eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2013 Mar;56(3):257-62.
224. Kohli A, Garcia M, Miller R, Maher C, Humblet O, Hammond K, Nadeau KC.
Secondhand smoke in combination with ambient air pollution exposure is associated with
increased CpG methylation and decreased expression of IFN-γ in T effector cells and Foxp3
in T regulatory cells in children. J Clin Epigenet. 2012 Sep 25;4(1):17.
225. Abarbanel DN, Seki SM, Davies Y, Marlen N, Benavides JA, Cox K, Nadeau KC, Cox
KL. Immunomodulatory Effect of Vancomycin on Treg in Pediatric Inflammatory Bowel
Disease and Primary Sclerosing Cholangitis. J Clin Immunol. 2013 Feb;33(2):397-406.
226. Kanai T, Jenks J, Nadeau KC. The STAT5b pathway defect and Autoimmunity. Front
Immunol. 2012; 3:234.
227. Swamy RS, Reshamwala N, Hunter T, Vissamsetti S, Santos CB, Baroody FM, Hwang
PH, Hoyte EG, Garcia MA, Nadeau KC. Epigenetic modifications and improved regulatory
T-cell function in subjects undergoing dual sublingual immunotherapy. J Allergy Clin
Immunol. 2012 Jul;130(1):215-224. (Recommended by Faculty 1000).
228. Gernez Y, Tirouvanziam R, Reshamwala N, Yu G, Weldon BC, Galli SJ, Herzenberg LA,
Nadeau KC. Modulation of mTOR effector phosphoproteins in blood basophils from
allergic patients. J Clin Immunol. 2012 Jun;32(3):565-73.
229. Yu GP, Weldon B, Neale-May S, Nadeau KC. The Safety of Peanut Oral
Immunotherapy in Peanut-Allergic Subjects in a Single-Center Trial. Int Arch Allergy
Immunol. 2012 Jun 1;159(2):179- 182
230. Bedoret D, Singh AK, Shaw V, Hoyte EG, Hamilton R, DeKruyff RH, Schneider LC,
Nadeau KC (co-senior author), Umetsu DT. Changes in antigen-specific T-cell number and
function during oral desensitization in cow's milk allergy enabled with omalizumab.
Mucosal Immunol. 2012 May;5(3):267- 76.
231. Morgan AA, Pyrgos VJ, Nadeau KC, Williamson PR, Butte AJ. Multiplex meta-
analysis of RNA expression to identify genes with variants associated with immune
dysfunction. J Am Med Inform Assoc. 2012 Mar-Apr;19(2):284-8. Interpretation of data.
27
232. Recher M, Burns S, de la Fuente MA, Volpi S, Dahlberg C, Walter J, Moffitt K,

Matthew D, Honke N, Lang, P, Patrizi L, Falet H, Keszei M, Mizui M, Csizmadia E,
Candotti F, Nadeau KC, Bouma G, Delmonte O, Frugoni F, Fomin A, Buchbinder D,
Lundequist E-M, Massaad MJ, Tsokos G, Hartwig J, Manis J, Terhorst C, Geha R, Snapper
S, Lang K, Malley R, Westerberg L, Thrasher A, Notarangelo L. B-cell- intrinsic
deficiency of the Wiskott-Aldrich syndrome protein causes severe abnormalities of the
peripheral B-cell compartment in mice. Blood. 2012 Mar 22;119(12):2819-28.
233. Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Chen R, Miriami E, Karczewski KJ,
Hariharan M, Dewey FE, Cheng Y, Clark MJ, Im H, Habegger L, Balasubramanian S,
O'Huallachain M, Dudley JT, Hillenmeyer S, Haraksingh R, Sharon D, Euskirchen G,
Lacroute P, Bettinger K, Boyle AP, Kasowski M, Grubert F, Seki S, Garcia M, Whirl-Carrillo
M, Gallardo M, Blasco MA, Greenberg PL, Snyder P, Klein TE, Altman RB, Butte AJ,
Ashley EA, Gerstein M, Nadeau KC, Tang H, Snyder M. Personal omics profiling
reveals dynamic molecular and medical phenotypes. Cell. 2012 Mar 16;148(6):1293-307.
234. Nadeau KC, Kohli A, Iyengar S, DeKruyff RH, Umetsu DT. Oral immunotherapy and
anti-IgE antibody-adjunctive treatment for food allergy. Immunol Allergy Clin North Am.
2012 Feb;32(1):111-33.
235. Pedroza L, Kumar V, Mace E, Nadeau KC, Perez E, Ruuskanen O, Orange J. AIRE
contributes to Dectin-1-induced TNF- α production 1 and complexes with CARD9, Syk,
and Dectin-1. J Allergy Clin Immunol. 2012 Feb;129(2):464-72.
236. Runyon RS, Cachola LM, Rajeshuni N, Hunter T, Garcia M, Ahn R, Lurmann F,
Krasnow R, Jack LM, Miller RL, Swan GE, Kohli A, Jacobson AC, and Nadeau KC. Asthma
discordance in twins is linked to epigenetic modifications of T cells. PLoS One.
2012;7(11): p. 487-496.
237. Ta V, Weldon B, Yu G, Humblet O, Neale-May S, Nadeau K. Use of Specific IgE and Skin
Prick Test to Determine Clinical Reaction Severity. British J. of Medicine.
2011;1(4):410-429.
238. Alonso M, Wang M, Utz PJ, Nadeau KC, Engleman E. Th1, Th2, and Th17 cells instruct
monocytes to differentiate into specialized dendritic cell subsets. Blood. 2011
Sep;118(12):3311-20.
239. Nadeau KC, Buchbinder D, Nugent D. Monozygotic Twin Pair Showing Discordant
Phenotype for X-linked Thrombocytopenia and Wiskott-Aldrich Syndrome: a Role for
Epigenetics? J Clin Immunol. 2011 Oct;31(5):773-7.
240. Nadeau KC, Schneider LC, Hoyte L, Borras I, Umetsu DT. Rapid oral desensitization in
combination with omalizumab therapy in patients with cow's milk allergy. J Allergy Clin
Immunol. 2011 Jun;127(6):1622-4.
241. Nguyen KD, Macaubas C, Nadeau KC, Truong P, Yoon T, Lee T, Park J, Mellins ED.
Serum amyloid A overrides Treg anergy via monocyte-dependent and Treg-intrinsic,
SOCS3-associated pathways. Blood. 2011. Apr 7;117(14):3793-8.
28
242. Nguyen T, Gernez Y, Fuentebella J, Patel A, Tirouvanziam R, Bass D, Berquist W, Cox K,

Kerner J, Nadeau K. Immunophenotyping of Peripheral Eosinophils Demonstrates
Activation in Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr. 2011 Jul;53(1):40-7.
243. Nadeau K, Hwa V, Rosenfeld R. STAT5b Deficiency: An Unsuspected Cause of Growth
Failure, Immunodeficiency, and Severe Pulmonary Disease. Medical Progress Article. J
Pediatr. 2011 May;158(5):701-8.
244. Nadeau K, Yu G, Berk D, de Saint Basile G, Lambert N, Knapnougel P, Roberts J, Kavanau
K, Dunn E, Stiehm R, Lewis DB, Umetsu DT, Puck J M, Cowan MJ. Genotype, Phenotype
and Outcomes of Nine Patients with T-B+NK+ SCID. Pediatr Transplant. 2011; 15: 7: 733-
741.
245. Nadeau K, Hyman-McDonald C, Hammond K, Balmes J, Tager I. Ambient Air
Pollution Impairs Regulatory T-Cell Function in Asthma. J Allergy Clin Immunol. 2010
Oct;126(4):845-852.
246. Kim YM, Munoz A, Hwang PH, Nadeau K. Migration of Regulatory T cells Toward Airway
Epithelial Cells Is Impaired in Chronic Rhinosinusitis with Nasal Polyposis. J. Clin
Immunol. 2010 Oct;137(1):111-21.
247. Gernez Y, Tirouvanziam R, Yu G, Ghosn E, Reshamwala N, Nguyen T, Tsai M, Galli S,
Herzenberg L, Herzenberg L, Nadeau K. Basophil CD203c levels are increased at baseline
and can be used to monitor omalizumab treatment in subjects with nut allergy. Int Arch
Allergy Immunol. 2010 Oct 25;154(4):318-327.
248. Huang JJ, Joh JW, Fuentebella J, Patel A, Nguyen T, Seki S, Hoyte EG, Reshamwala NP,
Nguyen C, Quiros A, Bass D, Sibley E, Berquist SW, Cox KL, Kerner J, Nadeau K. Eotaxin
and FGF enhance signaling through an Extracellular signal-related kinase (ERK)-
dependent pathway in the pathogenesis of Eosinophilic Esophagitis. Allergy Asthma Clinic
Immunol. 2010 Sep 5;6(1):25-34.
249. Patel AJ, Fuentebella J, Gernez Y, Nguyen T, Bas D, Berquist W, Cox K, Sibley E, Kerner
J, Nadeau K. Increased HLA-DR Expression on Tissue Eosinophils in Eosinophilic
Esophagitis. J Pediatr Gastroenterol Nutr. 2010 Sep;51(3):290-4.
250. Kudelko KT, De Jesus Perez V, Haddad F, Zamanian RG, Nadeau K, Leung A, Liu J.
Epoprostenol-Associated Pneumonitis: Diagnostic Use of a T Cell Proliferation Assay. J
Heart Lung Transplant. 2010 Sep;29(9):1071-5.
251. Fuentebella J, Patel A, Nguyen T, Sanjanwala B, Berquist W, Kerner KA, Bass D, Cox K,
Hurwitz M, Huang J, Nguyen C, Quiros JA, Nadeau K. Increased Number of Regulatory T
Cells in Children with Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr. 2010
Sep;51(3):283-9.
252. Boyd SD, Gaëta BA, Jackson KJ, Fire AZ, Marshall EL, Merker JD, Maniar JM, Zhang
LN, Sahaf B, Jones CD, Simen BB, Hanczaruk B, Nguyen KD, Nadeau K, Egholm M,
Miklos DB, Zehnder JL, Collins AM. Individual Variation in the Germline Ig Gene
Repertoire Inferred from Variable Region Gene Rearrangements. J Immunol. 2010 Jun
15;184(12):6986-92.
29
253. Nguyen K, Vanichsarn C, Nadeau K. TSLP directly impairs pulmonary Treg function:
association with aberrant tolerogenic immunity in asthmatic airway. Allergy Asthma Clin
Immunol. 2010 Mar 15:6(1):4-15.
254. Nelson K and Nadeau K. Bradykinin Inhibitors in Hereditary Angioedema. J Angioedema.
2010 Feb;1(1):27-30.
255. Boyd SD, Marshall E, Merker E, Maniar J, Zhang L, Sahaf B, Jones C, Simen B,
Hanczaruk B, Nguyen K, Nadeau K, Egholm D, Miklos D, Zehnder J, Fire AZ.
Measurement and clinical monitoring of human lymphocyte clonality by massively-
parallel IgH pyrosequencing. Sci Transl Med. 2009 Dec. 23;1(12):12-23.
256. Fuentebella J, Seki S, Nadeau K, Castillo RO. T lymphocytes and Its Subsets in
Transplanted Small Bowel Treated with Alemtuzumab (Campath-1H). Proceedings of the XI
International Small Bowel Transplant Symposium. 2009 Dec:37-42.
257. Nguyen KD, Vanichsarn C, Nadeau KC. Impaired IL-10-dependent induction of
tolerogenic dendritic cells by CD4+CD25hiCD127lo/-natural regulatory T cells in human
allergic asthma. Am J Respir Crit Care Med. 2009 Nov1;180: 823-33.
258. Gramatges M, Fani P, Pereira S, Nadeau K, Jeng M. Neonatal Alloimmune
thrombocytopenia and neutropenia associated with maternal HLA antibodies. Pediatr Blood
Cancer. 2009 Jul;53(1):97-9.
259. Yu G, Chiang D, Song SJ, Hoyte EG, Huang J, Vanishsarn C, Nadeau K. Regulatory T Cell
Dysfunction in Subjects with Common Variable Immunodeficiency Complicated by
Autoimmune Disease. Clin Immunol. 2009 May;131(2):240-53.
260. Nguyen K, Vanichsarn C, Fohner A, Nadeau K. Selective Deregulation in Chemokine
Signaling Pathways of CD4+CD25hiCD127lo/- Regulatory T Cells in Human Allergic
Asthma. J Allergy Clin Immunol. 2009 Apr;123(4):933-9.
261. Nguyen KD, Fohner A, Dong C, Krensky A, Nadeau K. XCL1 enhances regulatory
activities of CD4+CD25(high) CD127(low/-) T cells in human allergic asthma. J
Immunol. 2008 Oct 15;181(8):5386-95.
262. Nadeau K, Callejas A, Wong W, Joh J, Cohen H, Jeng M. Idiopathic neutropenia of
childhood is associated with Fas/FasL expression. Clin Immunol. 2008 Dec;129(3);438-
47.
263. Nguyen KD, Vanichsarn C, Nadeau, KC. Increased cytotoxicity of CD4+ invariant NKT
cells against CD4+CD25hiCD127lo/- regulatory T cells in allergic asthma. Eur J Immunol.
2008 Jul;38(7):2034-45.
264. Bhui D, Lewis DB, Nadeau K. A novel mutation associated with autoimmune
polyendocrinopathy- candidiasis-ectodermal dystrophy. Ann Allergy Asthma Immunol.
2008 Feb;100(2):169.
265. Gernez Y, Tirouvanziam R, Nguyen KD, Herzenberg LA, Krensky AM, Nadeau K. Altered
Phosphorylated Signal Transducer and Activator of Transcription Profile of CD4+CD161+
30
T Cells in Asthma: Modulation by Allergic Status and Oral Corticosteroids. J Allergy Clin
Immunol. 2007 Dec;120(6):1441-8
266. Cohen AC, Nadeau K, Tu W, Hwa V, Dionis K, Bezrodnik L, Teper A, Gaillard M, Heinrich
J, Krensky AM, Rosenfeld R, Lewis DB. Cutting edge: Decreased accumulation and
regulatory function of CD4+CD25(high) T cells in human STAT5b deficiency. J Immunol.
2006 Sep 1;177: 2770-4.
267. Cho CS, Burkly L, Fechner J, Kirk A, Oberley T, Dong Y, Brunner K, Peters D,
Tenhoor C, Nadeau K, Yagci G, Ishido N, Schultz J, Tsuchida M, Hamawy M,
Knechtle S. Successful conversion from conventional immunusuppression to anti- CD154
monoclonal antibody costimulatory molecule blockade in rhesus allograft recipients.
Transplantation. 2001 Aug 27;72(4):587-97.
268. Ziai F, Kusaka M, Nadeau K, MacKenzie H. Renal Allograft protection with losartan in
Fisher to Lewis rats: hemodynamics, macrophages, and cytokines. Kidney Int. 2000
Jun;57(6): 2618-25.
269. Ewenstein B, Hoots W, Lusher J, DiMichele D, Adelman B, Nadeau K. Inhibition of CD40
Ligand (CD154) in the treatment of Factor VIII Inhibitors. Haematologica. 2000
Oct;85(10 Suppl)35-9.
270. Tetaud E, Barrett M, Nadeau K, Walsh C, Fairlamb A. Cloning and characterization of two
enzymes responsible for trypanothione biosynthesis in C. fasciculata. J Biol Chem 1998
Jun 27;65(12):1533-42.
271. Kusaka M, Nadeau K, Takada M, Nagano H, Shaw G, Tilney N. Influence of initial
antigen- independent events on acute allograft rejection: inhibition by a soluable P- selectin
ligand and low-dose cyclosporine in combination. Transplantation Proc. 1998
Jun;30(4):1027-8.
272. Takada M, Nadeau K, Hancock W, Mackenzie H, Shaw G, Waaga A, Chandraker A, Sayegh
M, Tilney N. Effects of explosive brain death on cytokine activation of peripheral
organs in the rat. Transplantation. 1998 Jun 27;65(12):1533-42.
273. Chandraker A, Nadeau K, Carpenter C, Tilney N, Sayegh M. Late blockade of T cell
costimulation interrupts progression of experimental chronic allograft rejection. J. Clin.
Invest. 1998 Jun 1;101(11):2309-18.
274. Chandraker A, Takada M, Nadeau K, Peach R, Tilney N, Sayegh M. CD28-B7
Blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. Kidney Int.
1997 Dec;52(6):1678-84.
275. Takada M, Nadeau K, Shaw GD, Tilney NL. Prevention of late renal changes after initial
ischemia/reperfusion injury by blocking early selectin binding. Transplantation. 1997 Dec
15;64(11):1520-5.
276. Nagano H, Nadeau K, Kusaka M, Heeman UW, Tilney N. Infection-associated
macrophage activation accelerates chronic renal allograft rejection in rats.
Transplantation. 1997 Dec 15;64(11):1602-5.
31
277. Takada M, Chandraker A, Nadeau K, Sayegh M, Tilney N. The role of B7 costimulatory

pathway in experimental cold ischemia/reperfusion injury. J Clin Invest. 1997 Sep
1;100(5):1199-203.
278. Azuma H, Nadeau K, Takada M, Mackenzie HS, Tilney NL. Cellular and molecular
predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single
kidney. Transplantation. 1997 Jul 27; 64(2):190-7.
279. Takada M, Nadeau K, Shaw G, Tilney NL. The cytokine-adhesion molecule cascade in
ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P selectin ligand. J
Clin Invest. 1997 Jun 1; 99:2682-2690.
280. Nagano H, Nadeau K, Takada M, Kusaka M, Tilney NL. Sequential Cellular and
Molecular Kinetics in acutely rejecting renal allografts in rats. Transplantation. 1997 Apr
27;63(8):1101-1108.
281. Nadeau KC, Hannibal K, Sirkin S, Nightingale EO. Immigrating unaccompanied minors
—a neglected minority? West J Med. 1997 Mar;166(3):221-2.
282. Nadeau KC, Azuma H, Chandraker A, Sayegh M, Tilney NL. Inhibition of CD28-B7 T-cell
Costimulatory Activation Pathway Affects Intragraft Cytokine and Growth Factor
Expression in Chronic Renal Allograft Rejection. Transplantation Proc. 1997 Feb-Mar;29(1-
2):1038.
283. Azuma H, Nadeau KC, MacKenzie HS, Brenner BM, Tilney NL. Nephron Mass
Modulates the Hemodynamic, Cellular, and Molecular Response of the Rat Renal
Allograft. Transplantation. 1997 Feb 27;63(4):519-528.
284. Takada M, Nadeau KC, Shaw G, Tilney N. Early Cellular and Molecular Changes in
Ischemia/Reperfusion Injury: Inhibition by a Selectin Antagonist, P selectin
Glycoprotein Ligand-1. Transplantation Proc. 1997 Feb-Mar;29(1-2):1324-1325.
285. Azuma H, Nadeau KC, Takada M, Tilney NL. Initial Ischemia/Reperfusion Injury
Influences Late Functional and Structural Changes in the Kidney. Transplantation Proc.
1997 Feb-Mar;29(1-2):1528-9.
286. Nadeau KC, Azuma H, Tilney NL. Sequential cytokine expression in renal allografts in rats
immunosuppressed with maintenance cyclosporine or mycophenolate mofetil.
Transplantation. 1996 Nov 15;62(9):1363-6.
287. Nadeau KC and Tilney NL. Inflammatory mediators, cells, and their products in acute host
alloresponsiveness. Ann Transplant. 1996;1(3):5-13.
288. Azuma H, Chandraker A, Nadeau KC, Hancock WW, Carpenter CB, Tilney NL, Sayegh
MH. Blockade of T-cell costimulation prevents development of experimental chronic renal
allograft rejection. Proc Natl Acad Sci USA. 1996 Oct 29;93(22):12439-44.
289. Azuma H, Nadeau KC, Ishibashi M, Tilney NL. Prevention of functional, structural, and
molecular changes of chronic rejection of rat renal allografts by a specific macrophage
inhibitor. Transplantation. 1995 Dec 27;60(12):1577-1581.
32
290. Nadeau KC, Azuma H, Tilney NL. Cytokine Expression in Chronic Rejection of Rat Renal
Allografts: Roles for Cytokines RANTES and MCP-1. Proc Natl Acad Sci USA. 1995 Sep
12;92(19):8729-33.
291. Olson CL, Nadeau KC, Sullivan MA, Winquist AG, Donelson JE, Walsh CT, Engman DE.
Molecular and Biochemical Comparison of the 70 kDa Heat Shock Proteins of
Trypanosoma cruzi. J Biol Chem. 1994 Feb4;269(5):3868-3874.
292. Nadeau K, Nadler S, Tepper M, Walsh CT. Quantitation of the Interaction of the
Immunosuppressant Deoxyspergualin and Analogs with Hsc70 and Hsp90. Biochemistry.
1994 Mar8;33(9): 2561-2567.
293. Nadler S, Cleaveland J, Tepper M, Walsh CT, Nadeau KC. Studies on the Interaction of
Immunosuppressant 15-deoxyspergualin with Heat Shock Proteins. Ann NY Acad Sci. 1993
Jan 15;268(2): 412-14.
294. Nadeau KC, Das A, Walsh CT. Hsp90 Chaperonins Possess ATPase activity and Bind Heat
Shock Transcription Factors and Peptidyl Prolyl Isomerases. J. Biol Chem. 1993 Jan
15;268(2):1479-87.
295. Leichus BN, Bradley M, Nadeau K, Walsh CT, Blanchard JS. Kinetic isotope effect
analysis of the reaction catalyzed by Trypanosoma congolense trypanothione reductase.
Biochemistry. 1992 Jul 21;31(28):6414-20.
296. Nadeau K, Sullivan MA, Bradley M, Engman DE, Walsh CT. 83-Kilodalton heat shock
proteins of trypanosomes are potent peptide-stimulated ATPases. Protein Sci. 1992
Aug;1(8):970-9.
297. Smith K, Nadeau K, Bradley M, Walsh CT, Fairlamb AH. Purification of
Glutathionylspermidine and Trypanothione Synthetases from Crithidia fasciculata. Protein
Sci. 1992 Jul;1(7):874-883.
298. Walsh C, Bradley M, Nadeau K. Molecular studies on trypanothione reductase, a target
for antiparasitic drugs. Trends Biochem Sci. 1991 Aug;16(8):305-9.
299. Panton L, Tesh R, Nadeau K, Beverley S. A Test for Genetic Exchange in Mixed
Infections of Leishmania major in the Sand Fly Phlebotomus papatasi. J Protozool. 1991
Aug;16(8)224-228.
300. Leib DA, Nadeau KC, Rundle SA, Schaffer P. The promoter of the latency-associated
transcripts of Herpes Simplex Virus Type I contains a functional cAMP-response
element: Role of the latency-associated transcripts and cAMP in reactivation of viral latency.
Proc Natl Acad Sci USA. 1991 Jan 1;88(1):48-52.
B. Manuscripts in pre-print
1. Feyaerts D, Hedou J, Gillard J, Chen H, Tsai ES, Peterson LS, Ando K, Manohar M, Do E,
Dhondalay GKR, Fitzpatrick J, Artandi M, Chang I, Snow TT, Chinthrajah RS, Warren CM,
Wittman R, Meyerowitz JG, Ganio EA, Stelzer IA, Han X, Verdonk F, Gaudilliere DK,
Mukherjee N, Tsai AS, Rumer KK, Jiang SJ, Valdes-Ferrer SI, Kelly JD, Furman D,
Aghaeepour N, Angst MS, Boyd SD, Pinsky BA, Nolan GP, Nadeau KC, Gaudilliere B,
McIlwain DR. Integrated plasma proteomic and single-cell immune signaling network
33
signatures demarcate mild, moderate, and severe COVID-19. bioRxiv [Preprint]. 2021 Feb
10:2021.02.09.430269. doi: 10.1101/2021.02.09.430269.
2. Chang SE, Feng A, Meng W, Apostolidis SA, Mack E, Artandi M, Barman L, Bennett K,
Chakraborty S, Chang I, Cheung P, Chinthrajah S, Dhingra S, Do E, Finck A, Gaano A,
Geßner R, Giannini HM, Gonzalez J, Greib S, Gündisch M, Hsu AR, Kuo A, Manohar M,
Mao R, Neeli I, Neubauer A, Oniyide O, Powell AE, Puri R, Renz H, Schapiro JM,
Weidenbacher PA, Wittman R, Ahuja N, Chung HR, Jagannathan P, James J, Kim PS, Meyer
NJ, Nadeau K, Radic M, Robinson WH, Singh U, Wang TT, Wherry EJ, Skevaki C, Prak
ETL, Utz PJ. New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19.
medRxiv [Preprint]. 2021 Jan 29:2021.01.27.21250559. doi: 10.1101/2021.01.27.21250559.
1. Kaushik A, Dunham D, View He Z, Manohar M, Desai M, Nadeau KC, Andorf A.
CyAnno: A semi-automated approach for cell type annotation of mass cytometry datasets.
BioRxiv. https://doi.org/10.1101/2020.08.28.272559.
2. Kearney P, Getts R, Hayward C, Luta D, Porter A, Witmer M, du Toit G, Lack G,
Chinthrajah RS, Galli SJ, Nadeau K, Grishina G, Suarez-Farinas M, Suprun M, Sampson
HA. Highly Accurate and Reproducible Diagnosis of Peanut Allergy Using Epitope
Mapping. medRxiv. doi: https://doi.org/10.1101/2020.06.19.20136002.
3. Huang Y, Radenkovic D, Perez K, Nadeau K, Verdin E, Furman D. Age-dependent and
Independent Symptoms and Comorbidities Predictive of COVID-19 Hospitalization.
medRxiv. doi: https://doi.org/10.1101/2020.08.14.20170365
C. Non-Peer Reviewed Publications
4. Lancet Countdown, 2020: 2020 Lancet Countdown on Health and Climate Change Policy
Brief for the United States of America. Salas RN, Lester PK, Hess JJ. Lancet Countdown
U.S. Policy Brief, London, United Kingdom. https://www.lancetcountdownus.org/2020-
lancet-countdown-u-s-brief/
5. Co-Author of Book: “The End of Food Allergy: The First Program To Prevent and Reverse
a 21st Century Epidemic” Random House, NY, NY 2020. Release October 20.
D. Book Chapters
6. Block W, Sindher SB, Sampath V, Nadeau KC. "Sublingual and Oral Food
Immunotherapy: Indications, Preparation and Administration," in Allergens and Allergen
Immunotherapy - Subcutaneous, Sublingual and Oral, 6th edition, Chapter 28. Drs. Lockey
and Ledford, editors. CRC. 2020.
7. Long A, Bunning B, Sampath V, DeKruyff RH, Nadeau KC. “Epigenetics and the
Environment in Airway Disease: Asthma and Allergic Rhinitis,” in: Chang C, Lu Q, editors.
Epigenetics in Allergy and Autoimmunity. Advances in Experimental Medicine and
Biology, vol 1253. Springer, Singapore. 2020.
34
8. Rael E, Sampath V, Nadeau KC. “Diagnosis and Differential Diagnosis of Food Allergy
Chapter for Pediatric Food Allergy,” in: Ruchi Gupta, editor. Pediatric Food Allergy. A
Clinical Guide. Springer. 2020.
9. Nadeau KC. “Approach to the Patient with Allergic or Immunologic Disease,” in: Lee
Goldman L, Andy Schafer A, editors. Goldman-Cecil Medicine. Elsevier. 2019.
10. Prunicki MM, Nadeau KC. “The Air We Breathe: How Extreme Weather Conditions Harm
Us,” in: Steinberg SL, Sprigg WA, editors. Extreme Weather, Health, and Communities:
Interdisciplinary Engagement Strategies. Cham: Springer International Publishing; 2016.
p. 293-310.
11. Nadeau KC and Jeng, M, “Apoptosis and Pediatric Idiopathic Neutropenia,” in Present
Pediatric Reviews. Volume 7, No. 4, 321-328(8), Bentham Science Publishers, Nov.
2011.
12. Nadeau K, “T cell immunodeficiencies of the Neonate,” in Neonatology: Clinical Practice
and Procedural Atlas, edited by Ronald Cohen, Krisa Van Meurs, David Stevenson, 2011.
13. Hwa V, Nadeau K, Lit J, Rosenfeld R, “STAT5b Deficiency: Lessons from STAT5b Gene
Mutations,” in Best Practice and Research: Clinical Endocrinology and Metabolism, Vol.
25, No. 1, Feb. 2011.
14. Lewis DB, Cleary A, Nadeau K, “Primary Immunodeficiencies in Hematology,” in
Hematology: Basic Principles and Practice, 5th edition, Elsevier Science, 2006.
15. Nadeau K, “Anti-IgE therapy in Asthma in Allergy and Immunology,” in
Pharmacotherapy Handbook, 7th ed., McGraw Hill, 2006.
16. Nadeau K and Umetsu D, “The Pathology and Diagnosis of Asthma in Allergy: Guide
for Medical Students and Residents,” 3rd edition. Elsevier Science. 2005.
17. Nadeau K and Tilney NL, “The Role of Sequential Cytokine Analysis in Acute and
Chronic Allograft Rejection,” in Transplantation Reviews, Vol. 5, 99-107, 1996.
18. Nadeau K and Tilney NL, “Chronic Rejection,” in Organ Transplantation. Chap 14. 124-
150. edited by Morris, P, London, 1996.
19. Walsh C, Bradley M, Nadeau K, “Molecular Studies on Trypanothione Reductase: An
Anti-Parasitic Target Enzyme,” in Present Topics in Cellular Regulation, Vol. 33, 571- 574,
1992.
XI. Other
Editorial/Reviewer Service
 Associate Editor, Allergy
 Special Issue Editor, J. of Clinical Investigation
 Editorial Board, Clinical Immunology
 Editorial Board, Clinical Epigenetics
 Editorial Board, Journal of Allergy and Clinical Immunology
35
 Reviewer, Annals of Allergy and Immunology

 Reviewer, Mucosal Immunology
 Reviewer, Nature Immunology
 Reviewer, Nature Medicine
 Reviewer, Nature
 Reviewer, Journal of Clinical Immunology
 Reviewer, Journal of Clinical Investigation
 Reviewer, Journal of Rhinology
 Reviewer, Respiratory Research
 Reviewer, Journal of Immunology
 Reviewer, Journal of Pediatric Gastroenterology and Nutrition
 Reviewer, American Journal of Respiratory Cell and Molecular Biology
A. Patents
 Inventor, US Patent, entitled, “Methods and compositions for treating autoimmune and
allergic disorders” (filed 07/22/20)
 Inventor, US Patent No. 62/647,389, entitled “Inhibition of Allergic Reaction to Peanut
Allergen using an IL-33 Inhibitor” (filed 3/23/2018)
 Inventor, US Patent No. 62/119,014, entitled “Special Oral Formula for Decreasing
Food Allergy Risk and Treatment for Food Allergy” (filed 2/20/15, issued 8/15/17)
 Inventor, US Application No. S10-392, entitled “Basophil Activation Based Diagnostic
Allergy Test” (filed 10/1/2010)
 Inventor, US Application No. 12/686,121, entitled “Granulocyte-based methods for
detecting and monitoring immune system disorders” (filed 1/12/2010)
 Inventor, US Patent No. 12/610,940, entitled “Methods and Assays for Detecting
and Quantifying Pure Subpopulations of White Blood Cells in Immune System
Disorders” (filed 11/2/2009, issued 8/12/2018)
 Inventor, US Patent No 10/064,936, entitled “Mixed Allergen Compositions and Methods
for Using the Same” (issued 9/4/2018)
 Inventor, US Patent No 62/767,444 entitled, "Microfluidic Device and Diagnostic
Methods for Allergy Testing Based on Detection of Basophil Activation" (filed
11/14/2018)
B. Companies Co Founded
 Before Brands 2016; Menlo Park, CA
 Latitude 2018; Redwood City, CA
 Alladapt 2020; Menlo Park, CA
36
 IgGenix 2020; S. San Francisco, CA
C. Service as Grant Reviewer

 EAT (End Allergies Together) National Grant Review Committee (2017-2020)
 NIH Study Section member for Immune Studies-NIAID (2014-2018) and
Chairperson (October 2107) and K grant reviewer (2015-present)
 Respiratory Diseases, Saudi National Science Foundation (2014)
 American Lung Association National Grants (2013-present)
 Swiss National Science Foundation ad hoc review for grants (2014- present)
 U.S.-Israel Binational Science Foundation ad hoc review for grants (2013-2014)
 NIH NIAID Immune Tolerance Network (2013-present)
 Medical Research Council, United Kingdom ad hoc reviewer for National grants (2013-
present)
 AAAAI (American Academy of Allergy, Asthma, and Immunology) National Jr.
Faculty Award Committee for Review of Grants (2013-2014)
 NIH Aging Study Section, ad hoc member (2013)
 California Air Resources Board Scientific Review (2013-2018)
 Department of Defense Study Section (Food Allergy Research), ad hoc member (2013)
 NIH Special Study Section (Research with China), ad hoc member (2013)
 Food Allergy Research and Education (FARE) National Foundation (2012- 2018)
 NIH IRAP Study Section, ad hoc member (2012-2015)
 Stanford University School of Medicine McCormick Grant Program (2010- 2016)
 Children’s Hospital Research Program, CHRI Grant Reviewer LPCH (2007- present)
XII. Humanitarian Service

 Physicians for Human Rights (1989-2000)
 Amnesty International-supported work in Haiti (1993)
 Medical Clinic Volunteering in Masaya, Nicaragua (1985 and 1991)
 Outreach and education in Guatemala City, Guatemala (2014)
 Outreach and education in Tecate, Mexico (2013)
 Outreach and education in allergies and asthma East Palo Alto, Inner City Chicago, Harlem,
and San Francisco (2012-present)
 Stanford University Administrative Service
XIII. University Administrative Service

 Committee Service
 Member, Clinical Vaccine Policy, Stanford Hospital (2021 – present)
37
 Reviewer: Medical School applications (2020 - present)

 Reviewer: MD/PhD applications (2020 – present)
 Member, Department of Medicine’s Professoriate Appointments and Promotions
Committee (DoM A&P Committee (March 2020 - current)
 Member, Stanford University IRB, 2018-present
 Member, Search Committee, Faculty, Pulmonary and Critical Care Medicine
Division, Stanford School of Medicine, 2016-2017
 Global Health Summit Committee, 2015-2018
 BioMedical Innovation Executive Committee, 2015-present
 Scientific Oversight Committee member for Fellows in Department of Pediatrics (6
fellows to date), 2010-present
 Undergraduate Research Advisory Council, Stanford University, 2012-2018
 Stanford School of Medicine Core Facilities Advisory Board, 2011-2016
 Stanford Clinical and Translational Networking/Mentoring Program, 2010-2012
 Research Advisory Committee, Dept. of Pediatrics, 2009-present
 Women in Medicine Mentoring Program at Stanford, 2009-present
 Pre-Medical Student Advisor, 2006-present
 Leadership Roles at Stanford University

 Teaching
 COVID-19, Immunology, & Wildfire. Stanford Course: Epidemiology Research
Seminar (EPI 236). November 10, 2020. Virtual, Stanford, CA.
 SARS-CoV2 Vaccine Development. Stanford Course: Physicians and Social
Responsibility (MED228). November 9, 2020. Virtual, Stanford, CA.
 Climate and the Health Impacts of Air Pollution. Stanford Course: Bio 103 Human and
Planetary Health. October 12, 2020. Virtual, Stanford, CA.
 Innate lymphoid cells regulate tissue-specific immunity. Advanced Immunology II
(Immunol202, MCP 202). May 27, 2020. Stanford, CA.
 Design and conduct of early phase trials (non-oncology). HRP 251 Design and Conduct
of Clinical Trials. May 4, 2020. Stanford, CA
 Hypersensitivity and Allergy. IMM205/M&I 205 – Immunology Course. February 27,
2020. Stanford, CA.
 Wildfire-related air pollution and human health. CEE 265F and PubPol 265F -
Environmental Governance and Climate Resilience. February 25, 2020. Stanford, CA.
 Ways to Prevent, Diagnose, and Treat Children with Food Allergies. 2020 MCHRI
38
Seminar Series. February 3, 2020. Stanford, CA.

 Preventing and Managing Allergies. Prevention Across Medical Disciplines: Evidence-
based Course (CHPR 250). January 23, 2020. Stanford, CA.
 Climate Change and Children. The Impact of Climate Change on Human Health Course
(EMED 134/234). January 28, 2020. Stanford, CA.
 Immunology 202 (May 29, 2019). Advanced Immunology II: Innate lymphoid cells:
major players in inflammatory diseases. Stanford, CA.
 Freshman Undergraduate Seminar – Winter Quarters (2014-present) Undergraduate
students - WAYS course on “Translating Science to Disease Treatment.” Teach
about global health, climate change, and precision medicine.
 Undergraduate Independent Study (2008-present) Biology 199, Biology 99x
 Immunology 212 (Fall 2010) Biology of Granulocytes and Mast Cells in Human
Disease (Course Director)
 Immunology 209 (2010-2015) Graduate School Translational Medicine Course
 Immunology 205 Course (2010-present) Medical School Immunology Course
 Didactic Immunology and Allergy Sessions (since 1/2006) for ACGME- accredited
Fellowship
 Mentoring High School and Undergraduate Students, Residents, Fellows and
Researchers
 Postdoctoral Research Fellow, Yuan-Pang Hsieh,PhD, 2020- present
 Postdoctoral Research Fellow, Juan Aguilera, PhD, 2020-present
 Postdoctoral Research Fellow, James Krempski, PhD, 2020-2021
 Assistant Professor. Maya Kasowski, MD, PhD, 2020-Present
 Postdoctoral Fellow, Ziyuan He, PhD, 2019-2021
 Postdoctoral Fellow, Hesam Movassagh, PhD, 2019-2021
 Postdoctoral Fellow, Bibek Paudel, PhD, 2019-present
 Undergraduate Summer Intern, Rushali Patel, 2019
 High School Summer intern, David Cheng, 2019 (SIMR)
 High School Summer intern, Brandon Guo, 2019 (SIMR)
 Undergraduate Summer Intern, Lucas Melo, 2019
 High School Summer intern, Mathew Ho, 2019
 Undergraduate Summer Intern, Ayush Alag, 2019
 Postdoctoral Fellow, Shifaa Suhayl Alkotob, PhD, 2018-2020
 Postdoctoral Fellow, Abhinav Kaushik, PhD, 2018-present
 Postdoctoral Fellow, Arunachalam Ramaiah, PhD, 2018-2019
39
 Postdoctoral Scholar, Christopher Warren, PhD, 2019-present

 Postdoctoral Fellow, Xiaorui Han, PhD, 2018-present
 High School Summer intern, Matt Lim, 2018-2019
 Sr. Research Associate, Gopal Dhondalay, PhD, 2017-2020
 Assistant Professor, Tina Sindher, MD, 2017-present
 Postdoctoral Fellow and Instructor, Yu Wong, MD, PhD, 2016-present
 Undergraduate research, Akua Nyarko-Odoom, 2016-present
 Visiting Scholar, Fei Wang, MD, 2016-2017
 Assistant Professor, Chunrong Lin, MD, 2016-2017
 Visiting Scholar, Hye-Kyung Park, MD, 2015-2016
 Visiting Scholar, Arnon Elizur, MD, 2015-2015
 Instructor, Maya Kumar, PhD, 2015-2019
 Instructor, Hua Fan Minogue, PhD, 2015-2017
 Postdoctoral Fellow, Koshika Yadiva, PhD, 2015-2016
 Instructor, Jenna Bollyky, MD, 2015-2015
 Assistant Professor, Efren Rael, MD, 2015-2018
 Postdoctoral Fellow, Rebecca Bauer, PhD, 2014-2016
 Instructor, Mary Prunicki, MD, PhD, 2014-present
 Postdoctoral Fellow, Jaime Rosa, MD, PhD, 2014-2016
 Researcher, Ben Hobson, AB, 2014-2015
 Researcher, John Ryan, BS 2014-2015
 Postdoctoral Fellow, Michelle Toft Graham, PhD, 2013-2016
 Postdoctoral Fellow, Monali Manohar, PhD, 2013-2017
 Assistant and Associate Professor, Sharon Chinthrajah, MD, 2013-current
 Postdoctoral Fellow, Kinjal Hew, PhD, 2013-2015
 Postdoctoral Fellow, Laurence Pellerin, PhD, 2013-2017
 Researcher, Kimberly Vu, BS 2013-2014
 Researcher, Rachel Hovde, BS, 2013-2014
 Visiting Scholar, Unni Nygaard, PhD, 2013-2014
 Visiting Scholar, Satoru Ishida, MD, PhD, 2013-2014
 Visiting Scholar, Philippe Begin, MD, PhD, 2012-2014
 Visiting Scholar, Sr. Research Associate, Rosa Bacchetta, MD, 2012- 2014
 Postdoctoral Fellow, Annett Walker, MD, 2011-2013
40
 Postdoctoral Fellow, Takahiro Kanai, MD, PhD, 2011-2013

 Researcher, Aleena Syed, BS, 2011-2013
 Researcher, Jing Liu, BS, 2011-2013
 Postdoctoral Fellow and Instructor, Sandra Andorf, PhD, 2011-2019
 Postdoctoral Fellow, Minou Le-Carlson, MD, 2010-2012
 Postdoctoral Fellow, Olivier Humboldt, PhD, 2010-2012
 Postdoctoral Fellow, Amit Kumar Singh, PhD, 2010-2011
 Undergraduate student and Undergraduate Honors Thesis in Biology (Vice
Provost Grant) Jennifer Jenks, 2010-2015
 Undergraduate student, Scott Runyon, 2010-2012
Provost Grant) Robi Bucayu, 2010-2013
 Resident in Otolaryngology, Amanda Munoz, MD, 2009-2011
 Researcher, Tammie Nguyen, BS, 2009-2011
 Visiting Research Fellow in Otolaryngology, Seung Lee, MD, 2010-2012
 Resident in Pediatrics, Carah Santos, MD 2009-2011
 Academic Instructor in Adult Gastroenterology, Nielsen Fernandez-Becker, 2009-
2010
 Visiting Research Fellow in Otolaryngology, Soung Kim, MD, 2009-2010
Provost Grant), Jennifer Huang, 2009-2010
 Postdoctoral Fellow, Laurent Reber, PhD, 2009-2013
 Undergraduate student (Vice Provost Grant) Leslie Cachola, 2008-2012
Provost Grant) Marco Garcia, 2008-2012
 Undergraduate student (Vice Provost Grant) Scott Seki, 2008-2012
 Postdoctoral Fellow, Anup Patel, MD, 2008-2010
 Postdoctoral Fellow, Judy Fuentebella, MD, 2008-2010
 Postdoctoral Fellow, Neha Reshamwala, MD, 2008-2010
 Postdoctoral Fellow, Grace Yu, MD, 2007-2010
 Researcher, Yael Gernez, MD, 2007-2010
 Undergraduate Honors Thesis in Biology, David Chiang, 2007-2009
 Medical Scholars Program (Sohan Japa), Stanford Medical School, 2006- 2009
 Undergraduate Honors Thesis in Biology, Alison Fohner, 2006-2008
41
 Undergraduate student (Vice Provost Grant) Jae Joh, 2006-2007

 Other Leadership Roles
 2016-present: Section Chief, Asthma and Allergy Stanford School of Medicine
 2014-present: Director, Sean N. Parker Center for Allergy Research at
Stanford University, LPCH at El Camino Hospital, 2500 Grant Road, 4th floor,
Tower C, Mountain View, California 94040 USA.
 2009: Chairperson, Immunity, Transplantation, and Infectious Disease
Retreat. Stanford, CA
 2007-2011: Medical Director, Allergy and Immunology Clinics of Stanford
University School of Medicine
 2005-2011: Co-Program Director, Allergy and Immunology Fellowship
Program, Stanford University School of Medicine/Lucile Packard Children’s
Hospital
XIV. Service to Professional Organizations

A. Membership (Present)
 Wu Tsai Neurosciences Institute
 International Society of Global Health (ISoGH)
 Medical Society Consortium on Climate and Health
 Consortium of Universities for Global Health (CUGH)
 Royal Society of Medicine (RSM)
 American Thoracic Society
 American College of Allergy, Asthma, and Immunology
 American Academy of Allergy, Asthma and Immunology (AAAAI) American Academy of
Pediatrics, Fellow
 American Association of Immunologists Clinical Immunology Society
 Collegium Internationale Allergologicum
 European Academy of Allergy and Clinical Immunology
 Federation of Clinical Immunological Societies
 The American Society of Clinical Investigation
B. Committee Service (Present)
 Network Steering Committee of the NIAID Immune Tolerance Network
 Protocol Chair, Immune Tolerance Network, ITN087AD Anti-IL-33 Study
 Member, PrecISE Protocol Review Committee
 Member, AHRQ Committee, NIAID
42
 Member, Annual Meeting Program Committee for the American Academy of Asthma,
Allergy, and Immunology (AAAAI)
 Member, Board of Scientific Counselors of the NIH Clinical Center
 Member, Cells and Mediators of Allergic Inflammation Committee for the
American Academy of Asthma, Allergy, and Immunology (AAAAI)
 Member, Committee of American Academy of Asthma, Allergy, and Immunology
(AAAAI) on the underserved.
 Member, Committee on Food Allergy Clinical Studies, NIAID and Immune
Tolerance Network
 Member, Food Allergy Committee, NIAID
 Member, Core Centers Review Committee, NIEHS
 Member, DSMB, Novartis anti-CRTh2 compound (asthma indication)
Member, Interest Section Coordinating Committee for the American Academy of Asthma,
Allergy, and Immunology (AAAAI)
 Member, JACI Editorial Board for the American Academy of Asthma, Allergy, and
Immunology (AAAAI)
 Member, NHLBI Asthma Strategy National Committee
 Member, NIEHS Core Centers National Committee
 Member, Practice, Diagnostics and Therapeutics Committee for the American Academy of
Asthma, Allergy, and Immunology (AAAAI)
C. Leadership Roles
 2019: Organizer and Moderator Planetary Health Annual Meeting
 2018: Leader of Pediatric Forum at Governor’s Conference on Climate Change
 2018-present: Council Member for Collegium Internationale Allergologicum (CIA)
 2018-2019: NHLBI Protocol Review Committee (PRC) for the Precision Interventions for
Severe and/or Exacerbation Prone Asthma
 2018-present: NHLBI DSMB (Data Safety Monitoring Board)
 2017 (October): Chairperson, Mucosal Immunology Study Section, CSR/NIH
 2018: Chair and Founder, Gordon Research Conference, Food Allergy.
 2016-2018: Chairperson, Mechanisms in Allergy and Asthma Committee, AAAAI
 2015-2017: Working Group Leader for NIAID Workshop on Allergen Immunotherapy
 2014-2022: Committee on the Underserved, AAAAI
 2015-2017: Committee on Aerobiology and Pollution EAACI
 2015-2018: Environmental Health Policy Committee ATS
 2014-2015: NHLBI Advisory Committee for Asthma (NIH NHLBI)
43
 2014-2018: NIEHS Advisory Committee for Children’s Environmental Health Centers (NIH
NIEHS)
 2014: Institute of Medicine panel in Food Allergy
 2014-present: ITN Advisory Committee on Mechanistic Studies (NIH NIAID)
 2013-2014: Co Chair, 2014 International FOCIS Conference Planning Committee
 2013-2014: National Children’s Study Advisory Committee to the President of the U.S.
 2013-2014: Chair, FARE committee for training and mentoring Jr. Faculty in Research in
Food Allergy
 2013: Chair, Satellite Training Symposium Program, FOCIS June 2013 International
Meeting
 2013-2015: Secretary, Mechanisms of Allergy, Asthma and Immunology Section of AAAAI
 2012-2015: Scientific Advisory Board, No. California American Lung Association
 2012-2018: Chair, Interest Section of AAAAI: Mechanisms of Asthma and Allergic
Inflammation
 2012-present: Center of Excellence in Immunology Advisory Board, FOCIS
 2011-2012: National Meeting Leadership Committee Member of AAAAI
 2011-2014: Research Advisory Board, Food Allergy Research and Education
 2012-2018: California Air Resources Board Review Committee
 2009-2012: Task Force of the National Residency Match Program/Electronic Residency
Application Service, American Board of Allergy and Immunology
 2009-2013: Organizing Committee, Annual Clinical Immunology Society National
Conference
 2008-2013: Session chair for International Federation of Clinical Immunological Society
Conference
XV. Invited Lectures at International and National Conferences (from 2008)

1. Atopy as a Systems Disease: Translating Molecular Signals to Cures. Association of
American Physicians (AAP)/ASCI/APSA Joint Meeting. April 8-10, 2021. Virtual. Chicago,
IL. Virtual.
2. Understanding Climate change and health in vulnerable population: An example in the
Central Valley, CA. The 19th Annual Community Health Symposium: “Engaging
Communities in Health Equity Research” for the Office of Community Engagement and the
Office of Faculty Development and Diversity (OCE-OFDD). March 31, 2021. Stanford, CA.
Virtual.
3. Short & Long-Term Health Effects from Wildfires. The 8th State of the West Symposium for
the Bill Lane Center for the American West.March 30, 2021. Stanford, CA. Virtual.
44
4. Teaching Climate Change and Human Health in Medical Education. Academic Medicine
Podcast. March 26, 2021. Stanford, CA. Virtual.
5. Long COVID to Help Connect Researchers on this New and Important Issue. Long COVID:
invitation to participate in UK Gov-hosted Roundtable. March 24, 2021. United Kingdom.
Virtual.
6. Sublingual and Oral Food Immunotherapy. University of Miami Miller SoM CME Course.
March 13, 2021. Virtual.
7. Coffee Hour: A Networking Event for Global Health for the Consortium of Universities for
Global Health (CUGH). March 12, 2021, Virtual
8. Covid-19 — the Vaccines and Preparing for the New Normal. Stanford Health Care
Corporate Partners. March 10, 2021. Virtual.
9. Women in Science, an International Woman’s Day Special Panel Session. Asia Pacific
Association of Allergy, Asthma and Clinical Immunology (APAAACI). March 8, 2021.
Virtual Talk, London.
10. Digital health applications to clinical research in epidemics. Virtual Speaker for the Davos
Digital Forum. January 28, 2021. Zurich, Switzerland.
11. What we know about possible causes and cures for Food Allergy. Food Allergy Fund (FAF)
Vision Summit. December 16, 2020. Virtual, Stanford, CA.
12. Appropriate Governance for Safely Opening Oral Peanut Immunotherapy. Allergy Academy
Online, King's College London. November 25, 2020. Virtual, London, UK.
13. Immunotherapy for Food Allergy - Focus on Mechanisms. Allergy Postgraduate Programme at
Imperial College London. November 24, 2020. Virtual, London, UK.
14. Research Presentation: Human and Planetary Health. Stanford’s Woods Advisory Council
Meeting. October 23, 2020. Virtual, Stanford, CA.
15. Updates on COVID Vaccines. Parker Institute for Cancer Immunotherapy (PICI). October 17,
2020. Virtual, San Francisco, CA.
16. COVID-19 Vaccine Updates. Department of Medicine: Medicine Grand Rounds. October 14,
2020. Virtual, Stanford, CA.
17. Wildfire Updates. Department of Medicine: Medicine Grand Rounds. October 14, 2020.
Virtual, Stanford, CA.
18. COVID-19 Spread and Mitigation: Updates. Stanford George Shultz Group Meeting. October
12, 2020. Virtual, Stanford, CA.
19. Allergies are systemic diseases: Molecular mechanisms of multimorbidities. 14th World
Immune Regulation Meeting (WIRM) Conference. October 4-7, 2020. Virtual, Davos,
Switzerland.
20. The End of Food Allergies with Dr. Kari Nadeau and Sloan Barnett. Food Allergy Research
and Education (FARE): The 2020 Living Teal™ Global Summit. October 2, 2020. Virtual,
New York, NY. https://www.foodallergy.org/living-tealtm-global-summit-agenda
21. COVID-19 Vaccine Updates. Department of Surgery: Surgery Grand Rounds. October 6, 2020.
Virtual, Stanford, CA.
45
22. Panelist Speaker. Climate-Related Health Issues & Impact of Climate Change on Children’s
Health Climate-Related Heat & Respiratory Health Issues. Perspectives on Climate Change &
Public Health Conference for the NY Institute for Policy Integrity and the State Energy &
Environmental Impact Center at NYU School of Law. September 22, 2020. Virtual, New
York, NY.
23. Speaker on Webinar Panel. New Evidence on the Health Impacts of Wildfire Smoke. Stanford
Woods: Institute for the Environment. September 18, 2020. Virtual, Stanford, CA.
24. Keynote End Speech. NorCal Symposium on Climate and Pandemic Resilience in Healthcare.
September 25, 2020. Virtual, Stanford, CA.
25. What we know about possible causes and cures for Food Allergy? FARE 2020 Contains
Courage Research Retreat. September 21, 2020. Virtual, New York, NY
26. Climate change and children's health: what every pediatrician should know. 2nd annual
Advocating for Children Together (ACT) Continuing Medical Education (CME) Conference.
September 12, 2020. Virtual.
27. The Status of COVID-19 Vaccines. Stanford Medicine Grand Rounds. September 9, 2020.
Stanford, CA.
28. Integrative OMICs data analysis reveals key drivers of peanut allergic reactions. Virtual
European Academy of Allergy and Clinical Immunology (EAACI) Congress 2020. June 9,
2020. London, United Kingdom.
29. Multiple tree nut allergy: epidemiology, prevention and treatment? Virtual European
Academy of Allergy and Clinical Immunology (EAACI) Congress 2020. June 7, 2020.
London, United Kingdom.
30. Around the World in 20 min: Making Sense of Allergy Prevention Guidelines. 6th World
Congress of Pediatric Gastroenterology, Hepatology and Nutrition (WCPGHAN): Future
Nutritional Strategies for Food Allergy Prevention. Nestlé Health Science Online Symposium.
June 6, 2020. Vaud, Switzerland.
31. COVID-19: Immunity in Progress. Oxford University Sars-CoV-2 Lecture Series. June 4,
2020. Oxford, United Kingdom.
32. The Science and Status of COVID Vaccines. Stanford University, Department of Medicine
Grand Rounds. June 3, 2020. Stanford, CA.
33. Research progress of food allergy prevention and the research and development history of
SpoonfulOne. 6th Nestlé Health Science China Annual Nutrition Forum. May 30, 2020.
Beijing, China.
34. Health Care and the Climate Crisis. NEJM Resident 360 Interactive Discussion, February
13th - February 23rd, Online
35. Wildfires and Health. Stanford Center for Population Health Sciences (PHS). February 21,
2020. Stanford, CA.
36. Transfigurations of T cells during Tolerance. JOINT ITI CCHI U19/Gates/DRC Research
Meeting. February 19, 2020. Stanford, CA.
37. Translating Molecular Signals to Cures, Physician-Scientist Hour for the Stanford Medical
Scientist Training Program (MSTP). February 10, 2020. Stanford, CA.
46
38. The Impact of Climate Change on Human Health. Stanford Medicine Leadership Retreat
Climate Change. February 7, 2020. Half Moon Bay, CA.
39. Transforming Food Allergies Together. University of California, Los Angeles (UCLA).
January 23, 2020. Los Angeles, CA.
40. Considering the Health Impacts? Uncommon Dialog for the All-Electric Technical
Workshop. December 16, 2019. San José, CA.
41. New Prevention and Treatments of Food Allergy. Symposium at the occasion of the PhD
Defense of Suzanne Abbring at Utrecht University. December 11, 2019. Utrecht,
Amsterdam.
42. Management of the Multi-food Allergic Child Denver Allergy and Immunology Rounds
(DAR) at the National Jewish Health. December 4, 2019. Denver, CO.
43. Mechanisms of Prevention and Therapy in Food Allergy. Distinguished Scientist Seminar at
the National Jewish Health. December 4, 2019. Denver, CO.
44. What Oral Immuno Therapy teaches about Eosinophilic Esophagitis? Fifth Campaign
Urging Research for Eosinophilic Disease (CURED) from Eosinophilic Gastrointestinal
Diseases (EGID) Research and Patient Education Conference. November 6, 2019.
Cincinnati, OH.
45. Mechanisms of Immunology and Food Allergy. The Division of Allergy & Immunology at
the Cincinnati Children's Hospital Medical Center. November 5, 2019. Cincinnati, OH.
46. Prevent, Predict, Cure: The Future of Allergy & Asthma. Exponential Medicine. November
5, 2019. Coronado, CA.
47. Can understanding of epigenetics improve prevention? Pediatric Allergy and Asthma
Meeting (PAAM) at European Academy of Allergy and Clinical Immunology (EAACI).
October 19, 2017. Sicily, Italy.
48. A world without food allergy - fiction or reality. University Center for Health Sciences at the
Klinikum Augsburg (UNIKA-T) speaker series. October 16, 2019. Augsburg, Germany
49. Epidemiology on fire: Measuring the effect of the California conflagrations on health. Epi
Supper Club (ESC), Stanford University. October 7, 2019. Stanford, CA.
50. Allergic Diseases are Systemic Diseases. Swiss Institute of Allergy and Asthma Research
(SIAF) Symposium. September 27, 2019. Davos, Switzerland.
51. Mechanisms of Prevention and Therapy in Food Allergy. Stanford University, Department
of Medicine Grand Rounds. August 21 2019. Stanford, CA.
52. Mechanisms of Allergy Prevention and Therapy. Mayo Clinic Center for Immunology and
Immune Therapies, and the Mayo Clinic Graduate School of Biomedical Sciences –
Immunology Grand Rounds. June 20, 2019. Rochester, Minnesota.
53. Can food allergy be cured? European Academy of Allergy and Clinical Immunology
(EAACI) Congress. June 1-5, 2019. Lisbon, Portugal.
54. Approaches to prevention and treatment of allergies and for healthy living. 25th Annual
Stanford Alumni Healthy Living Retreat for Women. May 18, 2019. South Lake Tahoe, CA.
47
55. Studying Immunological Mechanisms to Try to End Food Allergy. ITI Human Immune
Monitoring Technology and Bioinformatics Conference at Stanford University. May 3,
2019. Stanford, CA.
56. Severe Asthma in a Changing World. Severe Asthma. Severe Asthma, Inflammation, and
Lung Repair. April 26, 2019. New York, NY.
57. Novel Therapies & Immune Regulation of Food Allergies. Keystone Symposia on Molecular
and Cellular Biology. Skin Health and Disease Immune, Epithelial and Microbiome
Crosstalk. April 11, 2019. Hannover, Germany.
58. Climate Change and Environmental Pollutants: Translating Research into Sound Policy for
Human Health and Well-being. Governance in an Emerging New World by George P.
Shultz (The Hoover Institution, Stanford University). April 8, 2019. Stanford, CA
59. Is There a Scientific Basis for Allergy as a “Systems Disease”?. Keystone Symposia
Conference - Origins of Allergic Disease: Microbial, Epithelial and Immune Interactions
(M3). March 25, 2019. Granlibakken Tahoe, Tahoe City, CA.
60. Understanding mechanisms of allergy and asthma and translating basic science findings to
clinical medicine. Medical Scientist Training Program (MSTP) Student Research
Symposium at Duke University School of Medicine. March 14, 2019. Durham, North
Carolina.
61. Preventing and Managing Allergies. Community Health & Prevention Research (CHPR)
250. CHPR 250: Prevention across Medical Disciplines. March 6, 2019. Stanford, CA.
62. Hypersensitivity and Allergy. Immunology in Human Health and Disease Course
(IMM205/M&I 205). March 4, 2019. Stanford, CA.
63. Immune Mechanisms Regulating Food Allergy Patheogenesis. American Academy of
Allergy, Asthma, & Immunology (AAAAI). February 23, 2019. San Francisco, CA.
64. Epigenetics and Food Allergy. American Academy of Allergy, Asthma, & Immunology
(AAAAI). February 22, 2019. San Francisco, CA.
65. Mechanisms of Immunotherapy. Institute for Immunity, Transplantation and Infection (ITI)
– JOINT ITI, U19, Gates, DRC Series. February 20, 2019. Stanford, CA.
66. Wildfires and Health. Stanford Center for Innovation in Global Health - Stanford Planetary
Health Speaker Series. February 20, 2019. Stanford, CA.
67. Molecular Mechanisms in Food Allergy Studies. Boston Children’s Hospital. January 31,
2019. Boston, MA.
68. The Future of Food Allergy. AllerGen 2019 Research Conference -Innovation from Cell to
Society9: An Impactful Past ~ A Formidable Future. January 30, 2019. Toronto, Canada.
69. Immunophenotyping of children with AD. Asthma and Allergic Diseases Cooperative
Research Centers Steering Committee Meeting (AADCRC). November 5, 2018. Rockville,
MD.
70. Studying Immunological Mechanisms to Try to End Food Allergy. The Sixth Annual Yale
Immunobiology Student Symposium. November 1, 2018. New Haven, CT.
48
71. Mechanisms of action of IT. European Academy of Allergy and Clinical Immunology
(EAACI) and Food Allergy and Anaphylaxis Meeting (FAAM). October 2018. Copenhagen,
Denmark.
72. Prevention Approaches. International Food Allergy & Anaphylaxis Alliance (IFAAA) and
Food Allergy Research & Education (FARE). October 2018. Copenhagen, Denmark.
73. Knowledge of Pathways Causing Allergies Lead to Roads to Prevention. October 2018.
Third Annual United States Developmental Origins of Health and Disease Meeting (DOHaD
Society). Chapel Hill, NC.
74. Immune Mechanisms in Food Allergy. September 2018. Massachusetts General Hospital:
Immunology Seminar. Boston, MA.
75. Immunotherapy and Biologics, Multi-Allergen. July 2018. Aspen Allergy Conference.
Aspen, CO.
76. Novel Immune Subsets in Mechanisms of Immunotherapy. June 2018. University of
Washington Immunology Series. Seattle, WA.
77. Prevention and Treatment mechanisms of Food Allergy. April 2018. NIH Grand Rounds,
Bethesda, MD.
78. Mechanisms of Allergy and Asthma. MIT/Broad Institute. December 2017. Boston, Mass.
79. Extreme Weather Conditions, Global Climate Change, and Air Pollution effects on
Asthma. October 2017. Fresno, CA.
80. OIT to foods - what can our patients look forward to? 5th Pediatric Allergy and Asthma
Meeting (PAAM). October 2017. London, England.
81. Allergen Products for Diagnosis and Therapy: Regulation and Science. 15th International
Paul-Ehrlich-Seminar (Paul-Ehrlich-Institut and the US Food and Drug Administration).
September 2017. Homburg, Germany.
82. Epigenetic Mechanisms of Air Pollution-Induced Immune Dysfunction in Children.
Gorfdon Research Conference (Cellular and Molecular Mechanisms of Toxicity). August
2017. Andover, NH.
83. Early Intervention in Allergy Prevention. European Academy of Allergy and Clinical
Immunology (EAACI). June 2017. Helsinki, Finland.
84. Effect of Pollution on the Epigenetic Profile of T Cells in Asthma. American Thoracic
Society (ATS). May 2017. Washington DC.
85. Effects of Climate Change on Children and Adults with Asthma. American Thoracic
Society (ATS). May 2017. Washington DC.
86. Impact of Environmental Pollutants on T Cell Populations. American Thoracic Society
(ATS). May 2017. Washington DC.
87. Environmental Influences on Children's Pulmonary Health: Mulitfaceted Effects of
Tobacco Smoke on Immunity. American Thoracic Society (ATS). May 2017. Washington
DC.
49
88. Immunomics to Study Mechanisms of Tolerance in Food Allergy Immunotherapy. Swiss

Institute of Allergy and Asthma Research (SIAF). March 2017. Davos, Switzerland.
89. Precision Medicine in Food Allergy. World Immune Regulation Meeting (WIRM). March
2017. Davos, Switzerland.
90. Food OIT, EPIT and More. American College of Allergy, Asthma and Immunology.
November 2016. San Francisco, CA.
91. Oral Immunotherapy. American College of Allergy, Asthma and Immunology.
November 2016. San Francisco, CA.
92. Impact of Air Pollution on Immune Functions. 5th conference on prenatal Programming
and Toxicity (PPTOX V). November 2016. Kitakyushu-city, Fukuoka, Japan.
93. Food Allergy Update on Oral and Epicutaneous Immunotherapy. American College of
Allergy, Asthma and Immunology. November 2016. San Francisco, CA.
94. Allergies. Federation of Clinical Immunology Societies (FOCIS): European Advanced
Course in Basic & Clinical Immunology. October 2016. Paris, France.
95. Mechanisms of Immune Tolerance Informing Rational Vaccine Design in Allergy. Nature
Conference: Immune Profiling in Health and Disease. October 2016. Seattle,
Washington.
96. Epigenetics and Food Allergy. Food Allergy and Anaphylaxis Meeting (FAAM). October
2016. Rome, Italy.
97. Allergen Specific Immunotherapy and Induction of Immune Tolerance. Chinese
Academy of Medical Sciences (CAMS) and National Institute of Allergy and
Infectious Diseases (NIAID) Immunology and Infectious Workshop. September 2016.
Beijing, China.
98. Mechanisms of Immune Tolerance in Immunotherapy. From the Laboratory to the Clinic:
Getting Closer to a Cure? September 2016. Trinity College, Oxford.
99. Immune Mechanisms Associated with Food Immunotherapy. Federation of American
Societies of Experimental Biology. July 2016. Palm Beach, FL.
100. Immunology for Food Allergy. European Academy of Allergy and Clinical Immunology
Congress. June 2016. Vienna, Austria.
101. Mechanisms of Anti-IgE in Food Allergy Immunotherapy. NIAID IgE Regulation in
Allergic Diseases. April 2016. Bethesda, MD.
102. Epigenetic Regulation in Food Allergy. World Immune Regulation Meeting. March 2016.
Davos, Switzerland.
103. Clinical Trial Experience with Viaskin in Peanut Allergy: The Physician and Patient
Perspective. American Academy of Allergy, Asthma, & Immunology, March 2016. Los
Angeles, CA.
104. Mechanistic Studies in T Cells during Food Allergen Immunotherapy. American
Academy of Allergy, Asthma, & Immunology, March 2016. Los Angeles, CA.
50
105. Anti-Epithelial Cell-Derived Cytokine Therapies: Basic Mechanisms Underlying the

Development of New Therapies. American Academy of Allergy, Asthma, &
Immunology, March 2016. Los Angeles, CA.
106. Epigenetic Mechanisms that Modulate Food Allergy. American Academy of Allergy,
Asthma, & Immunology, March 2016. Los Angeles, CA.
107. Epigenetic Changes during Food Allergen Immunotherapy. American Academy of
Allergy, Asthma, & Immunology, March 2016. Los Angeles, CA.
108. Translating Epigenetics to Cellular Function and Health Outcomes. American
Association for the Advancement of Science. February 2016. Washington, DC.
109. Oral Immunotherapy – The Stanford Experience. Nadeau KC. Western Society of Allergy,
Asthma, & Immunology. January 2016. Maui, Hawaii.
110. Molecular Basis of Gut Barrier Dysfunction Leading to Food Allergy. Western Society
of Allergy, Asthma, & Immunology. January 2016. Maui, Hawaii.
111. Making & Breaking Immune Tolerance in Allergy & Asthma. John Hopkins Medical
School Grand Rounds. December 2015. Baltimore, MD.
112. New Breakthroughs in Allergy & Asthma. Stanford University, Department of Medicine
Grand Rounds. December 2015. Stanford, CA.
113. Immunotherapy for Food: Where do we stand? Nadeau KC. American College of Allergy,
Asthma, & Immunology. November 2015. San Antonio, TX.
114. Deciphering the Black Box of Food Allergy Mechanisms. American College of Allergy,
Asthma, & Immunology. November 2015. San Antonio, TX.
115. Mechanisms of breaking and making immune tolerance in humans. NIEHS Center for
Environmental Health. Columbia University. October 2015. New York, NY.
116. New Insights into Food Allergy Diagnosis and Therapy. Grand Rounds. Department of
Pediatrics. Texas Children’s. October 2015. Houston, TX.
117. Anti-IgE therapy in Food Allergies. International Food Allergy Conference. September
2015. Rome, Italy.
118. Air Pollution induced T cell dysfunction in Asthma. EuroTox International Meeting.
September 2015. Porto, Portugal.
119. Molecular and Cellular Diagnostics in Food Allergy. Institute of Medicine Panel on Food
Allergy. September 2015. Washington, DC.
120. The T Cell in Asthma Exacerbations: Friend or Foe? American Thoracic Society
International Conference. May 2015. Denver, CO.
121. Mechanistic approaches to epigenetics and toxicant exposures. The American
Association of Immunologists. May 2015. New Orleans, LA.
122. Food Allergy Therapy: Past, Present, Future. Grand Rounds. Department of
Pediatrics. Seattle Children’s. April 2015. Seattle, WA.
51
123. Food Allergy Therapy: Past, Present, Future. Pierson Dinner Lecture. April 2015. Seattle,
WA.
124. The Study of Impaired Systematic Immunity and Linked Epigenetic Modifications during
Exposure to Polycyclic Aromatic Hydrocarbons in Ambient Air Pollutions. The Society of
Toxicology Annual Meeting. March 2015. San Diego, CA.
125. Mechanisms of possible immune tolerance in antigen immunotherapy. Yale HTI Seminar
Series. January 2015. New Haven, CT.
126. New approaches in the Treatment of Allergies. Annual Meeting Speaker. New England
Allergy Society. October 2014. Waterford, Vermont.
127. Mechanisms of food allergy immunotherapy. Plenary Session. National Australian Allergy
and Immunology Conference. September 2014. Melbourne, Australia.
128. Food allergy and New Approaches to Diagnosis and Treatment. Annual Memorial
Lectureship. Mount Desert Island Biological Laboratories Lecture Series. July 2014.
Mount Desert Island, Maine.
129. Anti-IgE therapy for Food Allergy Immunotherapy. Plenary Session, European
Academy of Allergy and Clinical Immunology. June 2014. Copenhagen, Denmark.
130. Epigenetic Changes in Immune Tolerance in Asthma. Microbiology and Immunology
Lecture Series. University of Texas. April 2014. San Antonio, TX.
131. Updates in Food Allergy. Grand Rounds, Department of Pediatrics. University of Texas
Health Sciences. April 2014. San Antonio, TX.
132. Epigenetics in Allergy and Asthma. NIAID symposium at the AAAAI Annual Meeting.
February 2014. San Diego, CA.
133. Nutrition and Food Allergy and Asthma. Health and Nutrition National Conference.
May 2014. Dallas, TX.
134. Mechanisms in Immune Tolerance. Immunology Lecture Series. University of Southern
California. March 2014. Pasadena, CA.
135. Mechanisms of Allergy Immunotherapy: The role of Treg. NIAID-AAAAI symposium at
the International FOCIS Annual Meeting. June 2013. Boston, Mass.
136. Mechanisms of anti-IgE therapy for Food Allergy Immunotherapy. European
Academy of Allergy and Clinical Immunology. June 2013. Milan, Italy.
137. New Insights into Epigenetics in Allergy/Asthma. Allergy and Immunology Grand Rounds.
Massachusetts General Hospital and the Brigham and Women’s Hospital. June 2013.
Boston, Mass.
138. Environmental Links to Asthma. Asthma Educator Summit. American Lung Association.
The California Endowment. May 2013. Oakland, CA.
139. The Role of anti IgE in New Therapies in Food Allergy. Division of Allergy and
Immunology. Northwestern School of Medicine. May 2013. Chicago, IL.
52
140. Making and Breaking Immune Tolerance. Bloomberg School of Public Health. Johns
Hopkins University School of Medicine. April 2013. Baltimore, MD.
141. Mechanisms of high dose vs low dose food allergen immunotherapy. Division of Allergy
and Immunology. Mt Sinai School of Medicine. April 2013. New York, NY.
142. Tolerance in Food Allergy Oral Immunotherapy. International Conference on Food
Allergies. February 2013. Nice, France.
143. Epigenetic Changes in DNA in Children with Asthma. U.S. Asthma Summit. November
2012. San Francisco, CA.
144. Air Pollution and Asthma in Children and Adolescents. American Lung Association
Board Meeting, November 2012. Stanford, CA.
145. Primary Immunodeficiency and Autoimmune Disease. Immune Deficiency Foundation
Annual Patient and Family Conference. September 2012. Palo Alto, CA.
146. Food Allergy: Updates on Diagnosis and Treatments. Grand Rounds. Marin General
Hospital. September 2012. Marin, CA.
147. Dendritic Cells induce Treg in subjects undergoing OIT for Food Allergy. Collegium
Internationale Allergologicum. October 2012. Jeju, Korea.
148. Food Allergy: Updates on Diagnosis and Treatments. Grand Rounds. Santa Clara Valley
Medical Center. September 2012. Santa Clara, CA.
149. How Ambient Air Pollution could cause Immune Dysregulation. EPA/NIEHS
Children's Centers Webinar - Wednesday, June 13th 2012.
150. Mechanisms of Immunotherapy. NIAID Seminar. AAAAI (American Academy of Allergy
Asthma and Immunology National Conference). March 2012. Orlando, Fl.
151. Sublingual Immunotherapy using Dual Aeroallergens. Plenary Session. AAAAI. March
2012. Orlando, Fl.
152. New Tolerance Mechanisms in Food Allergies. Plenary Session. AAAAI. March 2012.
Orlando, Fl.
153. Eosinophilic Esophagitis: Update on Mechanisms and Therapy. Lucile Packard
Children’s Hospital Grand Rounds. January 2012. Stanford, CA.
154. Mechanisms of Polycyclic Aromatic Hydrocarbons in T cell impairment. Duke Medical
Center. Grand Rounds. January 2012. Durham, NC.
155. Epigenetic changes following ambient air pollution exposure. EPA/NIEHS Scientific
Group Meeting. University of North Carolina. January 2012. Chapel Hill, NC.
156. Dissecting the Immunological Link between Air Pollution and Asthma. San Mateo Hospital
Grand Rounds. September 2011. San Mateo, CA.
157. Mechanisms of Immune Tolerance in Allergy. NIAID Plenary Session, World Allergy
Congress. December 2011. Cancun, Mexico.
53
158. Epigenetic Tracking in Specific T Cell Subsets. EPA Summit Conference, Developing and
Exploring Linkages Between Public Health Indicators, Exposure and Hazard Data.
September 2011. Washington, D.C.
159. Pediatric Immunology and Allergy: Measurements of the Immune System to track
Environmental Exposure. Environmental Health Summit, National Children’s Study. NIH.
May 2011. Bethesda, MD.
160. Pediatric Allergic Disorders. Grand Rounds, Lucile Packard Children’s Hospital. April
2011. Stanford, CA.
161. Measuring Allergen Specific T Cell Responses in Clinical Research. AAAAI
(American Academy of Allergy Asthma and Immunology National Conference). March
2011. San Francisco, CA.
162. The Increasing Incidence of Childhood Allergies. Pediatric Otolaryngology Update 2011.
February 2011. Stanford, CA.
163. Mechanistic Immune Studies in Oral Immunotherapy for Food Allergy. Children’s
Memorial Hospital. January 2011. Chicago, IL.
164. Linking Ambient Air Pollution exposure to Impaired Treg function: Role of epigenetics.
Dartmouth Medical School. November 2010. Hanover, NH.
165. Tolerance in Immunotherapy Studies. International FOCIS meeting. June 2010. Boston,
MA.
166. Gastroenterological Disorders and Allergy. Continuing Medical Education Conference,
W Hotel. May, 2009. San Francisco, CA.
167. Food Allergy: New Diagnostics and New Therapies. Grand Rounds, Lucile Packard
Children’s Hospital. April 2009. Stanford, CA.
168. Treg Tolerance Markers in Immunotherapy. AAAAI National Conference, Invited Session
Speaker. March 2009. Washington, DC.
169. Update on Immunodeficiencies. Northern California Association of Allergy and
Immunology. January 2009. San Francisco, CA.
170. Mechanisms of Attenuations of Regulatory T cells in Human Disease. NIH, January 2009.
Bethesda, MD.
171. Treg dysfunction in Allergy Asthma. AAAAI National Conference, Session Speaker.
March 2008. Philadelphia, Penn.
XVI. Select Media

For further media links on allergy and climate change/pollution, visit
(https://med.stanford.edu/allergyandasthma/news/InTheMedia.html and
https://climatehealth.sites.stanford.edu/media.
1. There is no 'one size fits all' approach to treat severe asthma. Science Daily. April 13, 2021.
2. Give local governments the resources, responsibility to prevent wildfires, academic experts
and state officials urge. Stanford Daily. March 30, 2021
54
3. Study Finds Air Pollution Puts Children at Higher Risk of Disease in Adulthood. Pharmacy
Times. March 24, 2021
4. Celebrating Women in Science, an International Woman's Day Special. Santa Cruz Sentinel.
Mar 6, 2021.
5. Air Pollution Puts Kids at Higher Risk of Disease in Adulthood. Futurity. Feb 21, 2021.
6. A Rocky Road On The Way To Herd Immunity For COVID-19. Idea Stream. Feb 3, 2021.
7. Data from twins suggests that gut bacteria are important in food allergies. Scope - Stanford
Medicine. Jan 22, 2021.
8. The peanut snack that triggered a fresh approach to allergy prevention. Nature. Dec 2, 2020.
9. Kids, toxic smoke and inequality. NY Times. Dec 2, 2020.
10. Wildfires' effects on kids' health feared long-term. NY Times. Nov 29, 2020.
11. Wildfire Smoke Is Poisoning California’s Kids. Some Pay a Higher Price. NY Times. Nov 26,
2020.
12. COVID-19 CME Education: Chat about the impacts of the unprecedented wildfire activity in
the West Coast especially in light of the COVID-19 pandemic. Ruth Adewuya. Nov 20, 2020.
13. Book Review: Targeting the Bane of Food Allergies. Undark. Oct 23, 2020.
14. The other public health crisis. The Hill. Oct 23, 2020.
15. Why food allergies are on the rise. BBC Future. Oct 23, 2020.
16. Study looks into how, why COVID-19 impacts brain, memory. Local 4 News. Oct 16, 2020.
17. Family seeks answers about 'brain fog' after they all contracted COVID-19. ABC 6 News.
Oct 15, 2020.
18. Post-COVID Clinics Get Jump-Start From Patients With Lingering Illness. Kaiser Health
News (KHN). Sep 30, 2020.
19. Deaths from recent wildfire smoke could top 3K, Stanford researchers say. Palo Alto Online.
Sep 30, 2020.
20. Interview The End of Food Allergy. CNN. Sep 29, 2020.
21. Another scary thing about COVID: Survivors aren’t fully recovering. San Francisco
Chronicle. Sep 28, 2020.
22. Four Different Family Members. Four Different Covid-19 Outcomes.. The Wall Street
Journal. Sep 28, 2020.
23. ‘Long-Haulers’ Face Debilitating Chronic Health Issues Following Coronavirus Recovery.
KPIX5. Sep 25, 2020.
24. Seven Cigarettes a Day: Panel Reveals Health Toll of Wildfire Smoke. Courthouse News. Sep
18, 2020.
25. How to Protect Children from Wildfire Smoke. NYTimes. Sep 18, 2020.
55
26. The Potential Long-Term Health Effects From Smoke and How to Stay Protected. NBC Bay
Area. Sep 18, 2020.
27. COVID-19: A Rare Opportunity for Science? SciTechDaily. Jul 29, 2020.
28. Recent Headlines Suggest Coronavirus Immunity Doesn't Last. The Science is More
Reassuring. KQED. Jul 28, 2020.
29. First Phase III Vaccine Trial Underway, Government Seeks Thousands Of Volunteers. NPR
News. Jul 27, 2020.
30. How Long Will Immunity To The Coronavirus Last? NPR News. Jul 23, 2020.
31. Climate Change Is A Health Crisis, And Doctors Aren’t Prepared. Huffpost. May 23, 2020.
32. New study details show remdesivir speeds COVID-19 recovery, but doesn't help sickest
patients. Biopharma.com. May 23, 2020.
33. News Feature: To counter the pandemic, clinicians bank on repurposed drugs (Repurposed
drugs for COVID). Proceedings of National Academy of Sciences of USA (PNAs.org). May
19, 2020.
34. Allergies and Asthma in the COVID-19 Age. Health Talks. May 13, 2020.
35. Scientists Are Trying To Understand Whether People Can Be Immune To The Coronavirus.
NPR News. May 7, 2020.
36. Stanford reflects on Earth Day at 50: Kari Nadeau. Stanford News. Apr 22, 2020.
37. Researchers test anti-viral drug remdesivir against COVID-19. Medical Press. Apr 20, 2020.
38. The war on the virus: Scientists race to develop tests, drugs to stop coronavirus in its tracks.
Palo Alto Online. Apr 10, 2020.
39. Race, Pollution and the Coronavirus. NY Times. Apr 8, 2020.
40. In war against coronavirus, researchers fast-track tests of Ebola drug. Palo Alto Weekly. Apr
6, 2020.
41. Medical Monday: COVID-19 Clinical Trials. CBSN (5 KPIX) Bay Area. Apr 6, 2020.
42. Stanford researchers tackle COVID-19 from all angles. Stanford Daily. Apr 5, 2020.
43. Science World: Biology: Health & Disease Peanut Allergy Fix? ScienceWorld. Mar 16, 2020.
44. New success in treating allergies to peanuts and other foods. Science News for Students. Feb
6, 2020.
45. FDA Approves First Drug for Children’s Peanut Allergies — Here's How It Works.
Healthline. Feb 4, 2020.
46. Gut microbes may protect against food allergies. C&EN Global Enterprise. Jan 28, 2020.
47. The Ongoing Bushfires in Australia Are Exacerbating Asthma Symptoms and Causing
Respiratory Distress. Allure. Jan 23, 2020.
48. In Australia, the air poses a threat; people are rushing to hospitals in cities choked by smoke.
The Washington Post. Jan 12, 2020.
56
49. Feeding Babies and Toddlers to Protect Against Food Allergies. Allergic Living. Nov 26,
2019.
50. Nearly 6 million kids in the U.S. have food allergies. This woman is trying to change that. The
Lily. Nov 22, 2019.
51. How bad is this air for you? UpFront - 94.1 KPFA. Nov 20, 2019.
52. New injection halts peanut allergy for at least 2 weeks. Medical News Today. Nov 18, 2019.
53. Peanut allergy cure is imminent. Wales Online. Nov 15, 2019.
54. First Drug for Peanut Allergy Nears FDA Approval. Forbes. Sep 19, 2019.
55. How to Reduce Exposure to Air Pollution. NY Times. Aug 13, 2019.
56. Why parents are turning to a controversial treatment for food allergies. Salon. Aug 10, 2019.
57. Must Hear: Interview with Stanford Immunologist Dr Kari Nadeau – Defeating Food
Allergies. Snack Safely. Aug 9, 2019.
58. Why Parents Are Turning to a Controversial Treatment for Food Allergies. Undark. Aug 5,
2019.
59. Let's Focus on Food Allergy Prevention. TEDx Talks. Jun 6, 2019.
60. This Year's Bay Area Pollen Season Is Really Bad. Here's Why. KQED. May 20, 2019.
XVII. Policy Change

A. Actions Impacting Policy Change
 All electric ordinance in San Francisco effective 01/01/21

 California College on Science and Technology steering committee member Dr. Mary Prunicki
on The Costs of Wildfire in California An Independent Review of Scientific and Technical
Information released 10/29/20.
 LANCET Countdown on Health and Climate Change Policy Brief for the United States Of
America working group member Dr. Kari Nadeau, December, 2020
B. Policy Change Discussions with Congress or CA Legislature

 California College on Science and Technology forum on high priorities for California's budget
toward wildfire prevention, preparation, and mitigations: CA senators and assembly members
by Dr. Mary Prunicki on 02/12/21
 California Natural Resources Testimony on the health impacts of prescribed burns by Dr. Mary
Prunicki on November 9, 2020.
 Oral public comment to Environmental Protection Agency on Review of National Ambient Air
Quality Standards for Particulate Matter by Dr. Lisa Patel on 5/27/20 and and Dr. Mary
Prunicki on 5/22/20.
 Oral public comment to Environmental Protection Agency on science in decision-making rule
by Lisa Patel on 3/18/20
 Meeting with State Senator Jerry Hill on sustainable healthcare by Lisa Patel on 2/26/20
 Written public comment to Environmental Protection Agency Clean Car Act by Dr Mary
Prunicki on 09/22/18.
57
XVIII. Seed Grants Provided to Other Investigators

 Race Matters in Diagnostic Accuracy: Improving Recognition of Underdiagnosed and Rare diseases
in Racial and Ethnic Minorities. Rare Disease Recognition in Minorities- Presence for Racial Justice
Lab (Stanford Primary Care and Population Health). April 1, 2021.
 5-Minute Moment for Racial Justice in Healthcare: an educational intervention. 5Min Racial Justice
Medical Education (Stanford Hospital Medicine). Jan 4, 2021.
 Mapping the transcriptional and open chromatin landscapes of Tfh13 cells at singlecell resolution.
Dr. Adam Williams (The Jackson Laboratory for Genomic Medicine). Nov 1, 2020.
 Elizabeth Mellins (Pediatrics - Human Gene Therapy). Elizabeth Mellins Lab Support. Sep 1, 2020.
 “Stanford’s Role in Supporting First Responders and Essential Workers”, “Overview of Home
Symptom Monitoring for COVID-19” & “Predicting COVID-19 Patient Deterioration”. Steve Asch
& Stacie Vilendrer (Stanford Primary Care and Population Health). Apr 1, 2020.
 Identify DNA methylations associated with measures of obesity in mother-child pairs in the deprived
and global multi-ethnic birth cohorts. Mohsen Fathzadeh (Stanford). Mar 1, 2020.
 IgA testing to stratify clinical responses to food allergens. Dr. Stepahnie Eisenbarth (Yale). Nov 1,
2019.
 Stanford Presence 5: Presence for Racial Justice. Virtual Presence 5 (Stanford Primary Care and
Population Health). Oct 1, 2019.
 Stanford Meharry Initiatives. MeHarry Students Program (Stanford Bedside Medicine). Sep 1, 2019
 Innovation in Asthma and Toxic Stress Management. Center for Youth Wellness (Center for Youth
Wellness). Mar 1, 2019
 Relationship between health care, rainforest conservation, and human well-being: evaluating impact
of a 10 year program in Borneo. Giulio De Leo, Michele Barry (Stanford). Mar 1, 2019.
 STORK to understand the role of microbial exposures on childhood growth and immunity. Dr. Julie
Parsonnet (Stanford). Jan 1, 2019.
 Dare2B Healthy Campaign – Health and Wellness. DARE2B.org (DARE2B.org). Aug 1, 2018
 The Food Allergy Management in Low Income Youth Study: A Family-Centered Approach to
Improving Anaphylaxis Knowledge and Childhood Food Allergy Management Skills. Dr. Ruchi
Gupta (Northwestern University). Jun 1, 2018.
 The Food Allergy Management in Low Income Youth Study: A Family-Centered Approach to
Improving Anaphylaxis Knowledge and Childhood Food Allergy Management Skills. Dr. Mary
Tobin (Rush University Medical School). Jun 1, 2018
 Pilot study of skin barrier repair therapy for prevention of atopic diseases in young children in
Bangladesh. Dr. Gary Darmstadt (Stanford). Mar 1, 2018.
 Noninvasive diagnosis of tuberculosis through detection of cell-free DNA in plasma and urine. Drs.
Banaei, Hogan and Santiago (Stanford). Mar 1, 2018.
 Effects of omalizumab on induction of inhibitory food allergen-specific IgG during multi-allergen
oral immunotherapy. Dr. Hans Oettgen (Boston Children's Hospital). Nov 1, 2017.
 Health effects of living near unimproved brick kilns and a pilot path to improvement. Dr. Stephen
Luby (Stanford). May 1, 2017.
 Clinical Study with Miarobiota. Dr. Justin Sonnenberg and Dr. Christopher Gardner (Stanford). Mar
1, 2017.
 Understand and quantitate the epithelial and innate immune responses to a variety of nasal injuries
and challenges. Dr. Jayakar Nayak (Stanford). Mar 1, 2017.
 Breaking of allergen-specific tolerance by human rhinovirus infections. Dr. Mubeccal Akdis
(University of Zurich - SIAF). Jan 11, 2015.
 Adult Food Allergy Epidemiology Study. Dr. Ruchi Gupta (Northwestern University). Jan 1, 2014.
58
XIX. Funding – Available Upon Request
59

Kari Nadeau CV

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Kari Nadeau CV

Uploaded by

Copyright:

Available Formats

CURRICULUM VITAE FOR KARI C.

NADEAU, MD, PHD

 California Medical License: G85871

III. Google Scholar Indices

VI. Professional Appointments (Stanford University School of Medicine)

 Aug. 2011-May 2015: Associate Professor of Pediatrics (MCL), Division of Allergy,

VII. Other Employment History

VIII. Honors and Awards

 Soma Weiss Speaker for Harvard Medical School (1993)

IX. Policy and Community Service/Outreach

 Member, Board of Directors, Lupus Foundation of Massachusetts (1998-2000)

1. Krempski JW, Warren C, Han X, Zhang W, He Z, Lejeune S, Nadeau K. Food Allergies: An

subcutaneous and sublingual immunotherapy. J Allergy Clin Immunol. 2021

78. Eiwegger T, Anagnostou K, Arasi S, Bégin P, Ben-Shoshan M, Beyer K, Blumchen K,

89. Breiteneder H, Diamant Z, Eiwegger T, Fokkens WJ, Traidl-Hoffmann C, Nadeau K,

autoimmune regulator-dependent autoimmunity. J Allergy Clin Immunol. 2015

Wood R. Food Allergy: A practice parameter update-2014. J Allergy Clin Immunol.

232. Recher M, Burns S, de la Fuente MA, Volpi S, Dahlberg C, Walter J, Moffitt K,

242. Nguyen T, Gernez Y, Fuentebella J, Patel A, Tirouvanziam R, Bass D, Berquist W, Cox K,

277. Takada M, Chandraker A, Nadeau K, Sayegh M, Tilney N. The role of B7 costimulatory

C. Non-Peer Reviewed Publications

 Reviewer, Annals of Allergy and Immunology

 IgGenix 2020; S. San Francisco, CA

C. Service as Grant Reviewer

XII. Humanitarian Service

XIII. University Administrative Service

 Reviewer: Medical School applications (2020 - present)

 Leadership Roles at Stanford University

Seminar Series. February 3, 2020. Stanford, CA.

 Postdoctoral Scholar, Christopher Warren, PhD, 2019-present

 Postdoctoral Fellow, Takahiro Kanai, MD, PhD, 2011-2013

 Undergraduate student (Vice Provost Grant) Jae Joh, 2006-2007

XIV. Service to Professional Organizations

XV. Invited Lectures at International and National Conferences (from 2008)

88. Immunomics to Study Mechanisms of Tolerance in Food Allergy Immunotherapy. Swiss

105. Anti-Epithelial Cell-Derived Cytokine Therapies: Basic Mechanisms Underlying the

XVI. Select Media

XVII. Policy Change

 All electric ordinance in San Francisco effective 01/01/21

B. Policy Change Discussions with Congress or CA Legislature

XVIII. Seed Grants Provided to Other Investigators

XIX. Funding – Available Upon Request

You might also like